CN115109128A - Peanut ralstonia solanacearum effect protein RipXV and coding gene and application thereof - Google Patents
Peanut ralstonia solanacearum effect protein RipXV and coding gene and application thereof Download PDFInfo
- Publication number
- CN115109128A CN115109128A CN202210674475.3A CN202210674475A CN115109128A CN 115109128 A CN115109128 A CN 115109128A CN 202210674475 A CN202210674475 A CN 202210674475A CN 115109128 A CN115109128 A CN 115109128A
- Authority
- CN
- China
- Prior art keywords
- ripxv
- ralstonia solanacearum
- protein
- leu
- gene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 102
- 241000589771 Ralstonia solanacearum Species 0.000 title claims abstract description 78
- 102000004169 proteins and genes Human genes 0.000 title claims abstract description 66
- 235000020232 peanut Nutrition 0.000 title claims abstract description 23
- 235000010777 Arachis hypogaea Nutrition 0.000 title claims abstract description 21
- 230000000694 effects Effects 0.000 title claims abstract description 20
- 235000017060 Arachis glabrata Nutrition 0.000 title claims abstract description 19
- 235000018262 Arachis monticola Nutrition 0.000 title claims abstract description 19
- 241001553178 Arachis glabrata Species 0.000 title claims 4
- 241000196324 Embryophyta Species 0.000 claims abstract description 28
- 239000012636 effector Substances 0.000 claims abstract description 26
- 238000000034 method Methods 0.000 claims abstract description 18
- 230000002018 overexpression Effects 0.000 claims abstract description 15
- 230000007918 pathogenicity Effects 0.000 claims abstract description 11
- 239000002773 nucleotide Substances 0.000 claims abstract description 5
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 5
- 125000003275 alpha amino acid group Chemical group 0.000 claims abstract 2
- 239000013598 vector Substances 0.000 claims description 34
- 241000894006 Bacteria Species 0.000 claims description 12
- 201000010099 disease Diseases 0.000 claims description 11
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 11
- 238000012258 culturing Methods 0.000 claims description 9
- 230000009261 transgenic effect Effects 0.000 claims description 6
- 238000012216 screening Methods 0.000 claims description 5
- 208000035240 Disease Resistance Diseases 0.000 claims description 4
- 241000232299 Ralstonia Species 0.000 claims description 4
- 230000014509 gene expression Effects 0.000 claims description 2
- 208000026935 allergic disease Diseases 0.000 claims 1
- 230000004665 defense response Effects 0.000 claims 1
- 244000105624 Arachis hypogaea Species 0.000 abstract description 22
- 230000001580 bacterial effect Effects 0.000 abstract description 21
- 238000010276 construction Methods 0.000 abstract description 20
- 230000003993 interaction Effects 0.000 abstract description 12
- 230000001052 transient effect Effects 0.000 abstract description 7
- 230000001717 pathogenic effect Effects 0.000 abstract description 5
- 230000008569 process Effects 0.000 abstract description 5
- 238000001086 yeast two-hybrid system Methods 0.000 abstract description 5
- 231100000252 nontoxic Toxicity 0.000 abstract description 4
- 230000003000 nontoxic effect Effects 0.000 abstract description 4
- 241000208125 Nicotiana Species 0.000 abstract description 3
- 239000002299 complementary DNA Substances 0.000 abstract description 3
- 230000006801 homologous recombination Effects 0.000 abstract description 3
- 238000002744 homologous recombination Methods 0.000 abstract description 3
- 230000030833 cell death Effects 0.000 abstract description 2
- 238000005516 engineering process Methods 0.000 abstract 1
- 230000009456 molecular mechanism Effects 0.000 abstract 1
- 238000003752 polymerase chain reaction Methods 0.000 description 21
- 108020004414 DNA Proteins 0.000 description 19
- 238000006243 chemical reaction Methods 0.000 description 18
- 239000012634 fragment Substances 0.000 description 9
- 241000207746 Nicotiana benthamiana Species 0.000 description 8
- 239000013612 plasmid Substances 0.000 description 8
- 238000012408 PCR amplification Methods 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 6
- 241001052560 Thallis Species 0.000 description 6
- GLNADSQYFUSGOU-GPTZEZBUSA-J Trypan blue Chemical compound [Na+].[Na+].[Na+].[Na+].C1=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(/N=N/C3=CC=C(C=C3C)C=3C=C(C(=CC=3)\N=N\C=3C(=CC4=CC(=CC(N)=C4C=3O)S([O-])(=O)=O)S([O-])(=O)=O)C)=C(O)C2=C1N GLNADSQYFUSGOU-GPTZEZBUSA-J 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 238000010186 staining Methods 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 244000052616 bacterial pathogen Species 0.000 description 5
- 238000010367 cloning Methods 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 241000588724 Escherichia coli Species 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- YBAFDPFAUTYYRW-UHFFFAOYSA-N N-L-alpha-glutamyl-L-leucine Natural products CC(C)CC(C(O)=O)NC(=O)C(N)CCC(O)=O YBAFDPFAUTYYRW-UHFFFAOYSA-N 0.000 description 4
- 108010093965 Polymyxin B Proteins 0.000 description 4
- 230000007123 defense Effects 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 239000013604 expression vector Substances 0.000 description 4
- 238000011081 inoculation Methods 0.000 description 4
- 229930027917 kanamycin Natural products 0.000 description 4
- 229960000318 kanamycin Drugs 0.000 description 4
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 4
- 229930182823 kanamycin A Natural products 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 230000017074 necrotic cell death Effects 0.000 description 4
- 239000013642 negative control Substances 0.000 description 4
- 230000003950 pathogenic mechanism Effects 0.000 description 4
- 229920000024 polymyxin B Polymers 0.000 description 4
- 229960005266 polymyxin b Drugs 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 239000008223 sterile water Substances 0.000 description 4
- 238000011144 upstream manufacturing Methods 0.000 description 4
- 241000589158 Agrobacterium Species 0.000 description 3
- 101000658547 Escherichia coli (strain K12) Type I restriction enzyme EcoKI endonuclease subunit Proteins 0.000 description 3
- 101000658543 Escherichia coli Type I restriction enzyme EcoAI endonuclease subunit Proteins 0.000 description 3
- 101000658546 Escherichia coli Type I restriction enzyme EcoEI endonuclease subunit Proteins 0.000 description 3
- 101000658530 Escherichia coli Type I restriction enzyme EcoR124II endonuclease subunit Proteins 0.000 description 3
- 101000658540 Escherichia coli Type I restriction enzyme EcoprrI endonuclease subunit Proteins 0.000 description 3
- 101000658545 Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd) Type I restriction enyme HindI endonuclease subunit Proteins 0.000 description 3
- 102000003960 Ligases Human genes 0.000 description 3
- 108090000364 Ligases Proteins 0.000 description 3
- 101000658548 Methanocaldococcus jannaschii (strain ATCC 43067 / DSM 2661 / JAL-1 / JCM 10045 / NBRC 100440) Putative type I restriction enzyme MjaIXP endonuclease subunit Proteins 0.000 description 3
- 101000658542 Methanocaldococcus jannaschii (strain ATCC 43067 / DSM 2661 / JAL-1 / JCM 10045 / NBRC 100440) Putative type I restriction enzyme MjaVIIIP endonuclease subunit Proteins 0.000 description 3
- 101000658529 Methanocaldococcus jannaschii (strain ATCC 43067 / DSM 2661 / JAL-1 / JCM 10045 / NBRC 100440) Putative type I restriction enzyme MjaVIIP endonuclease subunit Proteins 0.000 description 3
- 101001042773 Staphylococcus aureus (strain COL) Type I restriction enzyme SauCOLORF180P endonuclease subunit Proteins 0.000 description 3
- 101000838760 Staphylococcus aureus (strain MRSA252) Type I restriction enzyme SauMRSORF196P endonuclease subunit Proteins 0.000 description 3
- 101000838761 Staphylococcus aureus (strain MSSA476) Type I restriction enzyme SauMSSORF170P endonuclease subunit Proteins 0.000 description 3
- 101000838758 Staphylococcus aureus (strain MW2) Type I restriction enzyme SauMW2ORF169P endonuclease subunit Proteins 0.000 description 3
- 101001042566 Staphylococcus aureus (strain Mu50 / ATCC 700699) Type I restriction enzyme SauMu50ORF195P endonuclease subunit Proteins 0.000 description 3
- 101000838763 Staphylococcus aureus (strain N315) Type I restriction enzyme SauN315I endonuclease subunit Proteins 0.000 description 3
- 101000838759 Staphylococcus epidermidis (strain ATCC 35984 / RP62A) Type I restriction enzyme SepRPIP endonuclease subunit Proteins 0.000 description 3
- 101000838756 Staphylococcus saprophyticus subsp. saprophyticus (strain ATCC 15305 / DSM 20229 / NCIMB 8711 / NCTC 7292 / S-41) Type I restriction enzyme SsaAORF53P endonuclease subunit Proteins 0.000 description 3
- 230000000172 allergic effect Effects 0.000 description 3
- 108010043240 arginyl-leucyl-glycine Proteins 0.000 description 3
- 108010040443 aspartyl-aspartic acid Proteins 0.000 description 3
- 208000010668 atopic eczema Diseases 0.000 description 3
- 230000003115 biocidal effect Effects 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 108010015792 glycyllysine Proteins 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 230000001404 mediated effect Effects 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 230000009466 transformation Effects 0.000 description 3
- IBIDRSSEHFLGSD-UHFFFAOYSA-N valinyl-arginine Natural products CC(C)C(N)C(=O)NC(C(O)=O)CCCN=C(N)N IBIDRSSEHFLGSD-UHFFFAOYSA-N 0.000 description 3
- HSTOKWSFWGCZMH-UHFFFAOYSA-N 3,3'-diaminobenzidine Chemical compound C1=C(N)C(N)=CC=C1C1=CC=C(N)C(N)=C1 HSTOKWSFWGCZMH-UHFFFAOYSA-N 0.000 description 2
- DVJSJDDYCYSMFR-ZKWXMUAHSA-N Ala-Ile-Gly Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(O)=O DVJSJDDYCYSMFR-ZKWXMUAHSA-N 0.000 description 2
- 101100379081 Emericella variicolor andC gene Proteins 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 206010020649 Hyperkeratosis Diseases 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- 101150090155 R gene Proteins 0.000 description 2
- RVMNUBQWPVOUKH-HEIBUPTGSA-N Thr-Ser-Thr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(O)=O RVMNUBQWPVOUKH-HEIBUPTGSA-N 0.000 description 2
- 238000000246 agarose gel electrophoresis Methods 0.000 description 2
- KOSRFJWDECSPRO-UHFFFAOYSA-N alpha-L-glutamyl-L-glutamic acid Natural products OC(=O)CCC(N)C(=O)NC(CCC(O)=O)C(O)=O KOSRFJWDECSPRO-UHFFFAOYSA-N 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 108010008355 arginyl-glutamine Proteins 0.000 description 2
- 230000000680 avirulence Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000001976 enzyme digestion Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 108010063718 gamma-glutamylaspartic acid Proteins 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 108010073628 glutamyl-valyl-phenylalanine Proteins 0.000 description 2
- 108010050848 glycylleucine Proteins 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 108010026333 seryl-proline Proteins 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 108010072986 threonyl-seryl-lysine Proteins 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 230000001131 transforming effect Effects 0.000 description 2
- 230000010474 transient expression Effects 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- 108700026215 vpr Genes Proteins 0.000 description 2
- 241000589155 Agrobacterium tumefaciens Species 0.000 description 1
- HHGYNJRJIINWAK-FXQIFTODSA-N Ala-Ala-Arg Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N HHGYNJRJIINWAK-FXQIFTODSA-N 0.000 description 1
- IMMKUCQIKKXKNP-DCAQKATOSA-N Ala-Arg-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@H](C)N)CCCN=C(N)N IMMKUCQIKKXKNP-DCAQKATOSA-N 0.000 description 1
- LWUWMHIOBPTZBA-DCAQKATOSA-N Ala-Arg-Lys Chemical compound NC(=N)NCCC[C@H](NC(=O)[C@@H](N)C)C(=O)N[C@@H](CCCCN)C(O)=O LWUWMHIOBPTZBA-DCAQKATOSA-N 0.000 description 1
- MCKSLROAGSDNFC-ACZMJKKPSA-N Ala-Asp-Gln Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O MCKSLROAGSDNFC-ACZMJKKPSA-N 0.000 description 1
- ZDYNWWQXFRUOEO-XDTLVQLUSA-N Ala-Gln-Tyr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O ZDYNWWQXFRUOEO-XDTLVQLUSA-N 0.000 description 1
- BEMGNWZECGIJOI-WDSKDSINSA-N Ala-Gly-Glu Chemical compound [H]N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(O)=O BEMGNWZECGIJOI-WDSKDSINSA-N 0.000 description 1
- PNALXAODQKTNLV-JBDRJPRFSA-N Ala-Ile-Ala Chemical compound C[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O PNALXAODQKTNLV-JBDRJPRFSA-N 0.000 description 1
- HQJKCXHQNUCKMY-GHCJXIJMSA-N Ala-Ile-Asp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](C)N HQJKCXHQNUCKMY-GHCJXIJMSA-N 0.000 description 1
- AWZKCUCQJNTBAD-SRVKXCTJSA-N Ala-Leu-Lys Chemical compound C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CCCCN AWZKCUCQJNTBAD-SRVKXCTJSA-N 0.000 description 1
- SOBIAADAMRHGKH-CIUDSAMLSA-N Ala-Leu-Ser Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O SOBIAADAMRHGKH-CIUDSAMLSA-N 0.000 description 1
- PIXQDIGKDNNOOV-GUBZILKMSA-N Ala-Lys-Gln Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(O)=O PIXQDIGKDNNOOV-GUBZILKMSA-N 0.000 description 1
- OQWQTGBOFPJOIF-DLOVCJGASA-N Ala-Lys-His Chemical compound C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N OQWQTGBOFPJOIF-DLOVCJGASA-N 0.000 description 1
- MSWSRLGNLKHDEI-ACZMJKKPSA-N Ala-Ser-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(O)=O MSWSRLGNLKHDEI-ACZMJKKPSA-N 0.000 description 1
- MMLHRUJLOUSRJX-CIUDSAMLSA-N Ala-Ser-Lys Chemical compound C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCCCN MMLHRUJLOUSRJX-CIUDSAMLSA-N 0.000 description 1
- NCQMBSJGJMYKCK-ZLUOBGJFSA-N Ala-Ser-Ser Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O NCQMBSJGJMYKCK-ZLUOBGJFSA-N 0.000 description 1
- SYIFFFHSXBNPMC-UWJYBYFXSA-N Ala-Ser-Tyr Chemical compound C[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O)N SYIFFFHSXBNPMC-UWJYBYFXSA-N 0.000 description 1
- BHFOJPDOQPWJRN-XDTLVQLUSA-N Ala-Tyr-Gln Chemical compound C[C@H](N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(N)=O)C(O)=O BHFOJPDOQPWJRN-XDTLVQLUSA-N 0.000 description 1
- 108700028369 Alleles Proteins 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- VBFJESQBIWCWRL-DCAQKATOSA-N Arg-Ala-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCNC(N)=N VBFJESQBIWCWRL-DCAQKATOSA-N 0.000 description 1
- UXJCMQFPDWCHKX-DCAQKATOSA-N Arg-Arg-Glu Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(O)=O)C(O)=O UXJCMQFPDWCHKX-DCAQKATOSA-N 0.000 description 1
- UISQLSIBJKEJSS-GUBZILKMSA-N Arg-Arg-Ser Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CO)C(O)=O UISQLSIBJKEJSS-GUBZILKMSA-N 0.000 description 1
- BVBKBQRPOJFCQM-DCAQKATOSA-N Arg-Asn-Leu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(O)=O BVBKBQRPOJFCQM-DCAQKATOSA-N 0.000 description 1
- NTAZNGWBXRVEDJ-FXQIFTODSA-N Arg-Asp-Asp Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O NTAZNGWBXRVEDJ-FXQIFTODSA-N 0.000 description 1
- YFBGNGASPGRWEM-DCAQKATOSA-N Arg-Asp-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCN=C(N)N)N YFBGNGASPGRWEM-DCAQKATOSA-N 0.000 description 1
- JSHVMZANPXCDTL-GMOBBJLQSA-N Arg-Asp-Ile Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O JSHVMZANPXCDTL-GMOBBJLQSA-N 0.000 description 1
- TTXYKSADPSNOIF-IHRRRGAJSA-N Arg-Asp-Phe Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O TTXYKSADPSNOIF-IHRRRGAJSA-N 0.000 description 1
- QAODJPUKWNNNRP-DCAQKATOSA-N Arg-Glu-Arg Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O QAODJPUKWNNNRP-DCAQKATOSA-N 0.000 description 1
- OGUPCHKBOKJFMA-SRVKXCTJSA-N Arg-Glu-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CCCN=C(N)N OGUPCHKBOKJFMA-SRVKXCTJSA-N 0.000 description 1
- ZZZWQALDSQQBEW-STQMWFEESA-N Arg-Gly-Tyr Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O ZZZWQALDSQQBEW-STQMWFEESA-N 0.000 description 1
- MMGCRPZQZWTZTA-IHRRRGAJSA-N Arg-His-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N MMGCRPZQZWTZTA-IHRRRGAJSA-N 0.000 description 1
- AGVNTAUPLWIQEN-ZPFDUUQYSA-N Arg-Ile-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N AGVNTAUPLWIQEN-ZPFDUUQYSA-N 0.000 description 1
- FFEUXEAKYRCACT-PEDHHIEDSA-N Arg-Ile-Ile Chemical compound CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(N)=N)[C@@H](C)CC)C(O)=O FFEUXEAKYRCACT-PEDHHIEDSA-N 0.000 description 1
- LVMUGODRNHFGRA-AVGNSLFASA-N Arg-Leu-Arg Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O LVMUGODRNHFGRA-AVGNSLFASA-N 0.000 description 1
- YBZMTKUDWXZLIX-UWVGGRQHSA-N Arg-Leu-Gly Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O YBZMTKUDWXZLIX-UWVGGRQHSA-N 0.000 description 1
- COXMUHNBYCVVRG-DCAQKATOSA-N Arg-Leu-Ser Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O COXMUHNBYCVVRG-DCAQKATOSA-N 0.000 description 1
- JCROZIFVIYMXHM-GUBZILKMSA-N Arg-Met-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CCSC)NC(=O)[C@@H](N)CCCN=C(N)N JCROZIFVIYMXHM-GUBZILKMSA-N 0.000 description 1
- AOHKLEBWKMKITA-IHRRRGAJSA-N Arg-Phe-Ser Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N AOHKLEBWKMKITA-IHRRRGAJSA-N 0.000 description 1
- JPAWCMXVNZPJLO-IHRRRGAJSA-N Arg-Ser-Phe Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O JPAWCMXVNZPJLO-IHRRRGAJSA-N 0.000 description 1
- SYFHFLGAROUHNT-VEVYYDQMSA-N Arg-Thr-Asn Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(O)=O SYFHFLGAROUHNT-VEVYYDQMSA-N 0.000 description 1
- JKRPBTQDPJSQIT-RCWTZXSCSA-N Arg-Thr-Met Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCSC)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N)O JKRPBTQDPJSQIT-RCWTZXSCSA-N 0.000 description 1
- QTAIIXQCOPUNBQ-QXEWZRGKSA-N Arg-Val-Asp Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O QTAIIXQCOPUNBQ-QXEWZRGKSA-N 0.000 description 1
- QLSRIZIDQXDQHK-RCWTZXSCSA-N Arg-Val-Thr Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O QLSRIZIDQXDQHK-RCWTZXSCSA-N 0.000 description 1
- KXFCBAHYSLJCCY-ZLUOBGJFSA-N Asn-Asn-Ser Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(O)=O KXFCBAHYSLJCCY-ZLUOBGJFSA-N 0.000 description 1
- COUZKSSMBFADSB-AVGNSLFASA-N Asn-Glu-Phe Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)N)N COUZKSSMBFADSB-AVGNSLFASA-N 0.000 description 1
- PLVAAIPKSGUXDV-WHFBIAKZSA-N Asn-Gly-Cys Chemical compound C([C@@H](C(=O)NCC(=O)N[C@@H](CS)C(=O)O)N)C(=O)N PLVAAIPKSGUXDV-WHFBIAKZSA-N 0.000 description 1
- HYQYLOSCICEYTR-YUMQZZPRSA-N Asn-Gly-Leu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(O)=O HYQYLOSCICEYTR-YUMQZZPRSA-N 0.000 description 1
- DJIMLSXHXKWADV-CIUDSAMLSA-N Asn-Leu-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(N)=O DJIMLSXHXKWADV-CIUDSAMLSA-N 0.000 description 1
- PLTGTJAZQRGMPP-FXQIFTODSA-N Asn-Pro-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CC(N)=O PLTGTJAZQRGMPP-FXQIFTODSA-N 0.000 description 1
- QXOPPIDJKPEKCW-GUBZILKMSA-N Asn-Pro-Arg Chemical compound C1C[C@H](N(C1)C(=O)[C@H](CC(=O)N)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O QXOPPIDJKPEKCW-GUBZILKMSA-N 0.000 description 1
- GFGUPLIETCNQGF-DCAQKATOSA-N Asn-Pro-His Chemical compound C1C[C@H](N(C1)C(=O)[C@H](CC(=O)N)N)C(=O)N[C@@H](CC2=CN=CN2)C(=O)O GFGUPLIETCNQGF-DCAQKATOSA-N 0.000 description 1
- SNYCNNPOFYBCEK-ZLUOBGJFSA-N Asn-Ser-Ser Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O SNYCNNPOFYBCEK-ZLUOBGJFSA-N 0.000 description 1
- SKQTXVZTCGSRJS-SRVKXCTJSA-N Asn-Tyr-Asp Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CC(=O)N)N)O SKQTXVZTCGSRJS-SRVKXCTJSA-N 0.000 description 1
- BEHQTVDBCLSCBY-CFMVVWHZSA-N Asn-Tyr-Ile Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O BEHQTVDBCLSCBY-CFMVVWHZSA-N 0.000 description 1
- NAPNAGZWHQHZLG-ZLUOBGJFSA-N Asp-Asp-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)N NAPNAGZWHQHZLG-ZLUOBGJFSA-N 0.000 description 1
- CELPEWWLSXMVPH-CIUDSAMLSA-N Asp-Asp-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CC(O)=O CELPEWWLSXMVPH-CIUDSAMLSA-N 0.000 description 1
- ACEDJCOOPZFUBU-CIUDSAMLSA-N Asp-Cys-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](CC(=O)O)N ACEDJCOOPZFUBU-CIUDSAMLSA-N 0.000 description 1
- JRBVWZLHBGYZNY-QEJZJMRPSA-N Asp-Gln-Trp Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O JRBVWZLHBGYZNY-QEJZJMRPSA-N 0.000 description 1
- LTXGDRFJRZSZAV-CIUDSAMLSA-N Asp-Glu-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)N LTXGDRFJRZSZAV-CIUDSAMLSA-N 0.000 description 1
- PAYPSKIBMDHZPI-CIUDSAMLSA-N Asp-Leu-Asp Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O PAYPSKIBMDHZPI-CIUDSAMLSA-N 0.000 description 1
- LIVXPXUVXFRWNY-CIUDSAMLSA-N Asp-Lys-Ala Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(O)=O LIVXPXUVXFRWNY-CIUDSAMLSA-N 0.000 description 1
- DPNWSMBUYCLEDG-CIUDSAMLSA-N Asp-Lys-Ser Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O DPNWSMBUYCLEDG-CIUDSAMLSA-N 0.000 description 1
- QSFHZPQUAAQHAQ-CIUDSAMLSA-N Asp-Ser-Leu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O QSFHZPQUAAQHAQ-CIUDSAMLSA-N 0.000 description 1
- GCACQYDBDHRVGE-LKXGYXEUSA-N Asp-Thr-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H]([C@H](O)C)NC(=O)[C@@H](N)CC(O)=O GCACQYDBDHRVGE-LKXGYXEUSA-N 0.000 description 1
- KNOGLZBISUBTFW-QRTARXTBSA-N Asp-Trp-Val Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](C(C)C)C(O)=O KNOGLZBISUBTFW-QRTARXTBSA-N 0.000 description 1
- USENATHVGFXRNO-SRVKXCTJSA-N Asp-Tyr-Asp Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CC(O)=O)C(O)=O)CC1=CC=C(O)C=C1 USENATHVGFXRNO-SRVKXCTJSA-N 0.000 description 1
- GFYOIYJJMSHLSN-QXEWZRGKSA-N Asp-Val-Arg Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O GFYOIYJJMSHLSN-QXEWZRGKSA-N 0.000 description 1
- GIKOVDMXBAFXDF-NHCYSSNCSA-N Asp-Val-Leu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O GIKOVDMXBAFXDF-NHCYSSNCSA-N 0.000 description 1
- 108091026890 Coding region Proteins 0.000 description 1
- XABFFGOGKOORCG-CIUDSAMLSA-N Cys-Asp-Leu Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O XABFFGOGKOORCG-CIUDSAMLSA-N 0.000 description 1
- YUZPQIQWXLRFBW-ACZMJKKPSA-N Cys-Glu-Ala Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O YUZPQIQWXLRFBW-ACZMJKKPSA-N 0.000 description 1
- CUXIOFHFFXNUGG-HTFCKZLJSA-N Cys-Ile-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)O)NC(=O)[C@H](CS)N CUXIOFHFFXNUGG-HTFCKZLJSA-N 0.000 description 1
- ZXCAQANTQWBICD-DCAQKATOSA-N Cys-Lys-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)N ZXCAQANTQWBICD-DCAQKATOSA-N 0.000 description 1
- 102000012410 DNA Ligases Human genes 0.000 description 1
- 108010061982 DNA Ligases Proteins 0.000 description 1
- 241000620209 Escherichia coli DH5[alpha] Species 0.000 description 1
- JFOKLAPFYCTNHW-SRVKXCTJSA-N Gln-Arg-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCC(=O)N)N JFOKLAPFYCTNHW-SRVKXCTJSA-N 0.000 description 1
- LJEPDHWNQXPXMM-NHCYSSNCSA-N Gln-Arg-Val Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(O)=O LJEPDHWNQXPXMM-NHCYSSNCSA-N 0.000 description 1
- IXFVOPOHSRKJNG-LAEOZQHASA-N Gln-Asp-Val Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O IXFVOPOHSRKJNG-LAEOZQHASA-N 0.000 description 1
- MCAVASRGVBVPMX-FXQIFTODSA-N Gln-Glu-Ala Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O MCAVASRGVBVPMX-FXQIFTODSA-N 0.000 description 1
- RGAOLBZBLOJUTP-GRLWGSQLSA-N Gln-Ile-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)O)NC(=O)[C@H](CCC(=O)N)N RGAOLBZBLOJUTP-GRLWGSQLSA-N 0.000 description 1
- HWEINOMSWQSJDC-SRVKXCTJSA-N Gln-Leu-Arg Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O HWEINOMSWQSJDC-SRVKXCTJSA-N 0.000 description 1
- YPMDZWPZFOZYFG-GUBZILKMSA-N Gln-Leu-Ser Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O YPMDZWPZFOZYFG-GUBZILKMSA-N 0.000 description 1
- JNENSVNAUWONEZ-GUBZILKMSA-N Gln-Lys-Asn Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(O)=O JNENSVNAUWONEZ-GUBZILKMSA-N 0.000 description 1
- ZEEPYMXTJWIMSN-GUBZILKMSA-N Gln-Lys-Ser Chemical compound NCCCC[C@@H](C(=O)N[C@@H](CO)C(O)=O)NC(=O)[C@@H](N)CCC(N)=O ZEEPYMXTJWIMSN-GUBZILKMSA-N 0.000 description 1
- FQCILXROGNOZON-YUMQZZPRSA-N Gln-Pro-Gly Chemical compound NC(=O)CC[C@H](N)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O FQCILXROGNOZON-YUMQZZPRSA-N 0.000 description 1
- NHMRJKKAVMENKJ-WDCWCFNPSA-N Gln-Thr-Leu Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O NHMRJKKAVMENKJ-WDCWCFNPSA-N 0.000 description 1
- WTJIWXMJESRHMM-XDTLVQLUSA-N Gln-Tyr-Ala Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C)C(O)=O WTJIWXMJESRHMM-XDTLVQLUSA-N 0.000 description 1
- MXOODARRORARSU-ACZMJKKPSA-N Glu-Ala-Ser Chemical compound C[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CCC(=O)O)N MXOODARRORARSU-ACZMJKKPSA-N 0.000 description 1
- MLCPTRRNICEKIS-FXQIFTODSA-N Glu-Asn-Gln Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O MLCPTRRNICEKIS-FXQIFTODSA-N 0.000 description 1
- SVZIKUHLRKVZIF-GUBZILKMSA-N Glu-Asn-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCC(=O)O)N SVZIKUHLRKVZIF-GUBZILKMSA-N 0.000 description 1
- DSPQRJXOIXHOHK-WDSKDSINSA-N Glu-Asp-Gly Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(O)=O DSPQRJXOIXHOHK-WDSKDSINSA-N 0.000 description 1
- IESFZVCAVACGPH-PEFMBERDSA-N Glu-Asp-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CCC(O)=O IESFZVCAVACGPH-PEFMBERDSA-N 0.000 description 1
- CGOHAEBMDSEKFB-FXQIFTODSA-N Glu-Glu-Ala Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O CGOHAEBMDSEKFB-FXQIFTODSA-N 0.000 description 1
- SJPMNHCEWPTRBR-BQBZGAKWSA-N Glu-Glu-Gly Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(O)=O SJPMNHCEWPTRBR-BQBZGAKWSA-N 0.000 description 1
- OGNJZUXUTPQVBR-BQBZGAKWSA-N Glu-Gly-Glu Chemical compound OC(=O)CC[C@H](N)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(O)=O OGNJZUXUTPQVBR-BQBZGAKWSA-N 0.000 description 1
- CUXJIASLBRJOFV-LAEOZQHASA-N Glu-Gly-Ile Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(O)=O CUXJIASLBRJOFV-LAEOZQHASA-N 0.000 description 1
- HVYWQYLBVXMXSV-GUBZILKMSA-N Glu-Leu-Ala Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(O)=O HVYWQYLBVXMXSV-GUBZILKMSA-N 0.000 description 1
- VSRCAOIHMGCIJK-SRVKXCTJSA-N Glu-Leu-Arg Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O VSRCAOIHMGCIJK-SRVKXCTJSA-N 0.000 description 1
- FBEJIDRSQCGFJI-GUBZILKMSA-N Glu-Leu-Ser Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O FBEJIDRSQCGFJI-GUBZILKMSA-N 0.000 description 1
- GJBUAAAIZSRCDC-GVXVVHGQSA-N Glu-Leu-Val Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(O)=O GJBUAAAIZSRCDC-GVXVVHGQSA-N 0.000 description 1
- SJJHXJDSNQJMMW-SRVKXCTJSA-N Glu-Lys-Arg Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O SJJHXJDSNQJMMW-SRVKXCTJSA-N 0.000 description 1
- CUPSDFQZTVVTSK-GUBZILKMSA-N Glu-Lys-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCC(O)=O CUPSDFQZTVVTSK-GUBZILKMSA-N 0.000 description 1
- YKBUCXNNBYZYAY-MNXVOIDGSA-N Glu-Lys-Ile Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O YKBUCXNNBYZYAY-MNXVOIDGSA-N 0.000 description 1
- YHOJJFFTSMWVGR-HJGDQZAQSA-N Glu-Met-Thr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)O)C(O)=O YHOJJFFTSMWVGR-HJGDQZAQSA-N 0.000 description 1
- BPLNJYHNAJVLRT-ACZMJKKPSA-N Glu-Ser-Ala Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O BPLNJYHNAJVLRT-ACZMJKKPSA-N 0.000 description 1
- HMJULNMJWOZNFI-XHNCKOQMSA-N Glu-Ser-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)O)N)C(=O)O HMJULNMJWOZNFI-XHNCKOQMSA-N 0.000 description 1
- JWNZHMSRZXXGTM-XKBZYTNZSA-N Glu-Ser-Thr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(O)=O JWNZHMSRZXXGTM-XKBZYTNZSA-N 0.000 description 1
- HGJREIGJLUQBTJ-SZMVWBNQSA-N Glu-Trp-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC(C)C)C(O)=O HGJREIGJLUQBTJ-SZMVWBNQSA-N 0.000 description 1
- KIEICAOUSNYOLM-NRPADANISA-N Glu-Val-Ala Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(O)=O KIEICAOUSNYOLM-NRPADANISA-N 0.000 description 1
- HQTDNEZTGZUWSY-XVKPBYJWSA-N Glu-Val-Gly Chemical compound CC(C)[C@H](NC(=O)[C@@H](N)CCC(O)=O)C(=O)NCC(O)=O HQTDNEZTGZUWSY-XVKPBYJWSA-N 0.000 description 1
- VIPDPMHGICREIS-GVXVVHGQSA-N Glu-Val-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O VIPDPMHGICREIS-GVXVVHGQSA-N 0.000 description 1
- FVGOGEGGQLNZGH-DZKIICNBSA-N Glu-Val-Phe Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 FVGOGEGGQLNZGH-DZKIICNBSA-N 0.000 description 1
- SOYWRINXUSUWEQ-DLOVCJGASA-N Glu-Val-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)CCC(O)=O SOYWRINXUSUWEQ-DLOVCJGASA-N 0.000 description 1
- XUDLUKYPXQDCRX-BQBZGAKWSA-N Gly-Arg-Asn Chemical compound [H]NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(O)=O XUDLUKYPXQDCRX-BQBZGAKWSA-N 0.000 description 1
- WKJKBELXHCTHIJ-WPRPVWTQSA-N Gly-Arg-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CCCN=C(N)N WKJKBELXHCTHIJ-WPRPVWTQSA-N 0.000 description 1
- MQVNVZUEPUIAFA-WDSKDSINSA-N Gly-Cys-Gln Chemical compound C(CC(=O)N)[C@@H](C(=O)O)NC(=O)[C@H](CS)NC(=O)CN MQVNVZUEPUIAFA-WDSKDSINSA-N 0.000 description 1
- MOJKRXIRAZPZLW-WDSKDSINSA-N Gly-Glu-Ala Chemical compound [H]NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O MOJKRXIRAZPZLW-WDSKDSINSA-N 0.000 description 1
- STVHDEHTKFXBJQ-LAEOZQHASA-N Gly-Glu-Ile Chemical compound [H]NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O STVHDEHTKFXBJQ-LAEOZQHASA-N 0.000 description 1
- QPCVIQJVRGXUSA-LURJTMIESA-N Gly-Gly-Met Chemical compound CSCC[C@@H](C(O)=O)NC(=O)CNC(=O)CN QPCVIQJVRGXUSA-LURJTMIESA-N 0.000 description 1
- HKSNHPVETYYJBK-LAEOZQHASA-N Gly-Ile-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)CN HKSNHPVETYYJBK-LAEOZQHASA-N 0.000 description 1
- FCKPEGOCSVZPNC-WHOFXGATSA-N Gly-Ile-Phe Chemical compound NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 FCKPEGOCSVZPNC-WHOFXGATSA-N 0.000 description 1
- LIXWIUAORXJNBH-QWRGUYRKSA-N Gly-Leu-His Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)CN LIXWIUAORXJNBH-QWRGUYRKSA-N 0.000 description 1
- TVUWMSBGMVAHSJ-KBPBESRZSA-N Gly-Leu-Phe Chemical compound NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 TVUWMSBGMVAHSJ-KBPBESRZSA-N 0.000 description 1
- MHXKHKWHPNETGG-QWRGUYRKSA-N Gly-Lys-Leu Chemical compound [H]NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(O)=O MHXKHKWHPNETGG-QWRGUYRKSA-N 0.000 description 1
- HHRODZSXDXMUHS-LURJTMIESA-N Gly-Met-Gly Chemical compound CSCC[C@H](NC(=O)C[NH3+])C(=O)NCC([O-])=O HHRODZSXDXMUHS-LURJTMIESA-N 0.000 description 1
- FGPLUIQCSKGLTI-WDSKDSINSA-N Gly-Ser-Glu Chemical compound NCC(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCC(O)=O FGPLUIQCSKGLTI-WDSKDSINSA-N 0.000 description 1
- SOEGEPHNZOISMT-BYPYZUCNSA-N Gly-Ser-Gly Chemical compound NCC(=O)N[C@@H](CO)C(=O)NCC(O)=O SOEGEPHNZOISMT-BYPYZUCNSA-N 0.000 description 1
- UVTSZKIATYSKIR-RYUDHWBXSA-N Gly-Tyr-Glu Chemical compound [H]NCC(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O UVTSZKIATYSKIR-RYUDHWBXSA-N 0.000 description 1
- KSOBNUBCYHGUKH-UWVGGRQHSA-N Gly-Val-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)CN KSOBNUBCYHGUKH-UWVGGRQHSA-N 0.000 description 1
- KZTLOHBDLMIFSH-XVYDVKMFSA-N His-Ala-Asp Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(O)=O KZTLOHBDLMIFSH-XVYDVKMFSA-N 0.000 description 1
- DZMVESFTHXSSPZ-XVYDVKMFSA-N His-Ala-Ser Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O DZMVESFTHXSSPZ-XVYDVKMFSA-N 0.000 description 1
- STWGDDDFLUFCCA-GVXVVHGQSA-N His-Glu-Val Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O STWGDDDFLUFCCA-GVXVVHGQSA-N 0.000 description 1
- RGPWUJOMKFYFSR-QWRGUYRKSA-N His-Gly-Leu Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(O)=O RGPWUJOMKFYFSR-QWRGUYRKSA-N 0.000 description 1
- WECYRWOMWSCWNX-XUXIUFHCSA-N Ile-Arg-Leu Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(C)C)C(O)=O WECYRWOMWSCWNX-XUXIUFHCSA-N 0.000 description 1
- NKRJALPCDNXULF-BYULHYEWSA-N Ile-Asp-Gly Chemical compound [H]N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(O)=O NKRJALPCDNXULF-BYULHYEWSA-N 0.000 description 1
- YBJWJQQBWRARLT-KBIXCLLPSA-N Ile-Gln-Ser Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(O)=O YBJWJQQBWRARLT-KBIXCLLPSA-N 0.000 description 1
- BEWFWZRGBDVXRP-PEFMBERDSA-N Ile-Glu-Asn Chemical compound [H]N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O BEWFWZRGBDVXRP-PEFMBERDSA-N 0.000 description 1
- SPQWWEZBHXHUJN-KBIXCLLPSA-N Ile-Glu-Ser Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O SPQWWEZBHXHUJN-KBIXCLLPSA-N 0.000 description 1
- LBRCLQMZAHRTLV-ZKWXMUAHSA-N Ile-Gly-Ser Chemical compound CC[C@H](C)[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O LBRCLQMZAHRTLV-ZKWXMUAHSA-N 0.000 description 1
- AMSYMDIIIRJRKZ-HJPIBITLSA-N Ile-His-His Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)N AMSYMDIIIRJRKZ-HJPIBITLSA-N 0.000 description 1
- KEKTTYCXKGBAAL-VGDYDELISA-N Ile-His-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CO)C(=O)O)N KEKTTYCXKGBAAL-VGDYDELISA-N 0.000 description 1
- BBQABUDWDUKJMB-LZXPERKUSA-N Ile-Ile-Ile Chemical compound CC[C@H](C)[C@H]([NH3+])C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C([O-])=O BBQABUDWDUKJMB-LZXPERKUSA-N 0.000 description 1
- MTONDYJJCIBZTK-PEDHHIEDSA-N Ile-Ile-Met Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCSC)C(=O)O)N MTONDYJJCIBZTK-PEDHHIEDSA-N 0.000 description 1
- HUORUFRRJHELPD-MNXVOIDGSA-N Ile-Leu-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N HUORUFRRJHELPD-MNXVOIDGSA-N 0.000 description 1
- RQQCJTLBSJMVCR-DSYPUSFNSA-N Ile-Leu-Trp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O)N RQQCJTLBSJMVCR-DSYPUSFNSA-N 0.000 description 1
- OTSVBELRDMSPKY-PCBIJLKTSA-N Ile-Phe-Asn Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(=O)N)C(=O)O)N OTSVBELRDMSPKY-PCBIJLKTSA-N 0.000 description 1
- XLXPYSDGMXTTNQ-UHFFFAOYSA-N Ile-Phe-Leu Natural products CCC(C)C(N)C(=O)NC(C(=O)NC(CC(C)C)C(O)=O)CC1=CC=CC=C1 XLXPYSDGMXTTNQ-UHFFFAOYSA-N 0.000 description 1
- CIDLJWVDMNDKPT-FIRPJDEBSA-N Ile-Phe-Phe Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)O)N CIDLJWVDMNDKPT-FIRPJDEBSA-N 0.000 description 1
- JZNVOBUNTWNZPW-GHCJXIJMSA-N Ile-Ser-Asp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)O)N JZNVOBUNTWNZPW-GHCJXIJMSA-N 0.000 description 1
- PMGDADKJMCOXHX-UHFFFAOYSA-N L-Arginyl-L-glutamin-acetat Natural products NC(=N)NCCCC(N)C(=O)NC(CCC(N)=O)C(O)=O PMGDADKJMCOXHX-UHFFFAOYSA-N 0.000 description 1
- FADYJNXDPBKVCA-UHFFFAOYSA-N L-Phenylalanyl-L-lysin Natural products NCCCCC(C(O)=O)NC(=O)C(N)CC1=CC=CC=C1 FADYJNXDPBKVCA-UHFFFAOYSA-N 0.000 description 1
- RCFDOSNHHZGBOY-UHFFFAOYSA-N L-isoleucyl-L-alanine Natural products CCC(C)C(N)C(=O)NC(C)C(O)=O RCFDOSNHHZGBOY-UHFFFAOYSA-N 0.000 description 1
- SENJXOPIZNYLHU-UHFFFAOYSA-N L-leucyl-L-arginine Natural products CC(C)CC(N)C(=O)NC(C(O)=O)CCCN=C(N)N SENJXOPIZNYLHU-UHFFFAOYSA-N 0.000 description 1
- 239000012880 LB liquid culture medium Substances 0.000 description 1
- PBCHMHROGNUXMK-DLOVCJGASA-N Leu-Ala-His Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC1=CN=CN1 PBCHMHROGNUXMK-DLOVCJGASA-N 0.000 description 1
- YOZCKMXHBYKOMQ-IHRRRGAJSA-N Leu-Arg-Lys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCCN)C(=O)O)N YOZCKMXHBYKOMQ-IHRRRGAJSA-N 0.000 description 1
- JKGHDYGZRDWHGA-SRVKXCTJSA-N Leu-Asn-Leu Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(O)=O JKGHDYGZRDWHGA-SRVKXCTJSA-N 0.000 description 1
- YKNBJXOJTURHCU-DCAQKATOSA-N Leu-Asp-Arg Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CCCN=C(N)N YKNBJXOJTURHCU-DCAQKATOSA-N 0.000 description 1
- ZURHXHNAEJJRNU-CIUDSAMLSA-N Leu-Asp-Asn Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O ZURHXHNAEJJRNU-CIUDSAMLSA-N 0.000 description 1
- DLFAACQHIRSQGG-CIUDSAMLSA-N Leu-Asp-Asp Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O DLFAACQHIRSQGG-CIUDSAMLSA-N 0.000 description 1
- LAGPXKYZCCTSGQ-JYJNAYRXSA-N Leu-Glu-Phe Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O LAGPXKYZCCTSGQ-JYJNAYRXSA-N 0.000 description 1
- POZULHZYLPGXMR-ONGXEEELSA-N Leu-Gly-Val Chemical compound CC(C)C[C@H](N)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O POZULHZYLPGXMR-ONGXEEELSA-N 0.000 description 1
- ORWTWZXGDBYVCP-BJDJZHNGSA-N Leu-Ile-Cys Chemical compound SC[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](N)CC(C)C ORWTWZXGDBYVCP-BJDJZHNGSA-N 0.000 description 1
- HGFGEMSVBMCFKK-MNXVOIDGSA-N Leu-Ile-Glu Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(O)=O HGFGEMSVBMCFKK-MNXVOIDGSA-N 0.000 description 1
- SEMUSFOBZGKBGW-YTFOTSKYSA-N Leu-Ile-Ile Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O SEMUSFOBZGKBGW-YTFOTSKYSA-N 0.000 description 1
- IAJFFZORSWOZPQ-SRVKXCTJSA-N Leu-Leu-Asn Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O IAJFFZORSWOZPQ-SRVKXCTJSA-N 0.000 description 1
- IEWBEPKLKUXQBU-VOAKCMCISA-N Leu-Leu-Thr Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O IEWBEPKLKUXQBU-VOAKCMCISA-N 0.000 description 1
- WXUOJXIGOPMDJM-SRVKXCTJSA-N Leu-Lys-Asn Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(O)=O WXUOJXIGOPMDJM-SRVKXCTJSA-N 0.000 description 1
- RZXLZBIUTDQHJQ-SRVKXCTJSA-N Leu-Lys-Asp Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(O)=O RZXLZBIUTDQHJQ-SRVKXCTJSA-N 0.000 description 1
- OVZLLFONXILPDZ-VOAKCMCISA-N Leu-Lys-Thr Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O OVZLLFONXILPDZ-VOAKCMCISA-N 0.000 description 1
- LZHJZLHSRGWBBE-IHRRRGAJSA-N Leu-Lys-Val Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(O)=O LZHJZLHSRGWBBE-IHRRRGAJSA-N 0.000 description 1
- KXCMQWMNYQOAKA-SRVKXCTJSA-N Leu-Met-Gln Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N KXCMQWMNYQOAKA-SRVKXCTJSA-N 0.000 description 1
- JVTYXRRFZCEPPK-RHYQMDGZSA-N Leu-Met-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)N)O JVTYXRRFZCEPPK-RHYQMDGZSA-N 0.000 description 1
- WMIOEVKKYIMVKI-DCAQKATOSA-N Leu-Pro-Ala Chemical compound [H]N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(O)=O WMIOEVKKYIMVKI-DCAQKATOSA-N 0.000 description 1
- DPURXCQCHSQPAN-AVGNSLFASA-N Leu-Pro-Pro Chemical compound CC(C)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(O)=O)CCC1 DPURXCQCHSQPAN-AVGNSLFASA-N 0.000 description 1
- RGUXWMDNCPMQFB-YUMQZZPRSA-N Leu-Ser-Gly Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CO)C(=O)NCC(O)=O RGUXWMDNCPMQFB-YUMQZZPRSA-N 0.000 description 1
- XOWMDXHFSBCAKQ-SRVKXCTJSA-N Leu-Ser-Leu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CC(C)C XOWMDXHFSBCAKQ-SRVKXCTJSA-N 0.000 description 1
- SBANPBVRHYIMRR-UHFFFAOYSA-N Leu-Ser-Pro Natural products CC(C)CC(N)C(=O)NC(CO)C(=O)N1CCCC1C(O)=O SBANPBVRHYIMRR-UHFFFAOYSA-N 0.000 description 1
- PPGBXYKMUMHFBF-KATARQTJSA-N Leu-Ser-Thr Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(O)=O PPGBXYKMUMHFBF-KATARQTJSA-N 0.000 description 1
- WFCKERTZVCQXKH-KBPBESRZSA-N Leu-Tyr-Gly Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)NCC(O)=O WFCKERTZVCQXKH-KBPBESRZSA-N 0.000 description 1
- FBNPMTNBFFAMMH-UHFFFAOYSA-N Leu-Val-Arg Natural products CC(C)CC(N)C(=O)NC(C(C)C)C(=O)NC(C(O)=O)CCCN=C(N)N FBNPMTNBFFAMMH-UHFFFAOYSA-N 0.000 description 1
- FZIJIFCXUCZHOL-CIUDSAMLSA-N Lys-Ala-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN FZIJIFCXUCZHOL-CIUDSAMLSA-N 0.000 description 1
- VHFFQUSNFFIZBT-CIUDSAMLSA-N Lys-Ala-Cys Chemical compound C[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CCCCN)N VHFFQUSNFFIZBT-CIUDSAMLSA-N 0.000 description 1
- NFLFJGGKOHYZJF-BJDJZHNGSA-N Lys-Ala-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN NFLFJGGKOHYZJF-BJDJZHNGSA-N 0.000 description 1
- WSXTWLJHTLRFLW-SRVKXCTJSA-N Lys-Ala-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(O)=O WSXTWLJHTLRFLW-SRVKXCTJSA-N 0.000 description 1
- LZWNAOIMTLNMDW-NHCYSSNCSA-N Lys-Asn-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCCCN)N LZWNAOIMTLNMDW-NHCYSSNCSA-N 0.000 description 1
- IBQMEXQYZMVIFU-SRVKXCTJSA-N Lys-Asp-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)N IBQMEXQYZMVIFU-SRVKXCTJSA-N 0.000 description 1
- RZHLIPMZXOEJTL-AVGNSLFASA-N Lys-Gln-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CCCCN)N RZHLIPMZXOEJTL-AVGNSLFASA-N 0.000 description 1
- NDORZBUHCOJQDO-GVXVVHGQSA-N Lys-Gln-Val Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(O)=O NDORZBUHCOJQDO-GVXVVHGQSA-N 0.000 description 1
- ULUQBUKAPDUKOC-GVXVVHGQSA-N Lys-Glu-Val Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O ULUQBUKAPDUKOC-GVXVVHGQSA-N 0.000 description 1
- KZJQUYFDSCFSCO-DLOVCJGASA-N Lys-His-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@H](CCCCN)N KZJQUYFDSCFSCO-DLOVCJGASA-N 0.000 description 1
- MXMDJEJWERYPMO-XUXIUFHCSA-N Lys-Ile-Arg Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O MXMDJEJWERYPMO-XUXIUFHCSA-N 0.000 description 1
- OVAOHZIOUBEQCJ-IHRRRGAJSA-N Lys-Leu-Arg Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O OVAOHZIOUBEQCJ-IHRRRGAJSA-N 0.000 description 1
- ZCWWVXAXWUAEPZ-SRVKXCTJSA-N Lys-Met-Glu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(O)=O ZCWWVXAXWUAEPZ-SRVKXCTJSA-N 0.000 description 1
- KFSALEZVQJYHCE-AVGNSLFASA-N Lys-Met-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)N KFSALEZVQJYHCE-AVGNSLFASA-N 0.000 description 1
- TWPCWKVOZDUYAA-KKUMJFAQSA-N Lys-Phe-Asp Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(O)=O)C(O)=O TWPCWKVOZDUYAA-KKUMJFAQSA-N 0.000 description 1
- LMGNWHDWJDIOPK-DKIMLUQUSA-N Lys-Phe-Ile Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O LMGNWHDWJDIOPK-DKIMLUQUSA-N 0.000 description 1
- DYJOORGDQIGZAS-DCAQKATOSA-N Lys-Ser-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)N DYJOORGDQIGZAS-DCAQKATOSA-N 0.000 description 1
- MIFFFXHMAHFACR-KATARQTJSA-N Lys-Ser-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CCCCN MIFFFXHMAHFACR-KATARQTJSA-N 0.000 description 1
- CAVRAQIDHUPECU-UVOCVTCTSA-N Lys-Thr-Thr Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O CAVRAQIDHUPECU-UVOCVTCTSA-N 0.000 description 1
- VHTOGMKQXXJOHG-RHYQMDGZSA-N Lys-Thr-Val Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(O)=O VHTOGMKQXXJOHG-RHYQMDGZSA-N 0.000 description 1
- 239000007987 MES buffer Substances 0.000 description 1
- IVCPHARVJUYDPA-FXQIFTODSA-N Met-Asn-Asp Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)O)N IVCPHARVJUYDPA-FXQIFTODSA-N 0.000 description 1
- KLFPZIUIXZNEKY-DCAQKATOSA-N Met-Gln-Met Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCSC)C(O)=O KLFPZIUIXZNEKY-DCAQKATOSA-N 0.000 description 1
- DBXMFHGGHMXYHY-DCAQKATOSA-N Met-Leu-Ser Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O DBXMFHGGHMXYHY-DCAQKATOSA-N 0.000 description 1
- BEZJTLKUMFMITF-AVGNSLFASA-N Met-Lys-Arg Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(O)=O)CCCNC(N)=N BEZJTLKUMFMITF-AVGNSLFASA-N 0.000 description 1
- HOZNVKDCKZPRER-XUXIUFHCSA-N Met-Lys-Ile Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O HOZNVKDCKZPRER-XUXIUFHCSA-N 0.000 description 1
- SMVTWPOATVIXTN-NAKRPEOUSA-N Met-Ser-Ile Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O SMVTWPOATVIXTN-NAKRPEOUSA-N 0.000 description 1
- VWFHWJGVLVZVIS-QXEWZRGKSA-N Met-Val-Asn Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O VWFHWJGVLVZVIS-QXEWZRGKSA-N 0.000 description 1
- VEKRTVRZDMUOQN-AVGNSLFASA-N Met-Val-His Chemical compound CSCC[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CC1=CNC=N1 VEKRTVRZDMUOQN-AVGNSLFASA-N 0.000 description 1
- PVSPJQWHEIQTEH-JYJNAYRXSA-N Met-Val-Tyr Chemical compound CSCC[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 PVSPJQWHEIQTEH-JYJNAYRXSA-N 0.000 description 1
- 108010002311 N-glycylglutamic acid Proteins 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- UHRNIXJAGGLKHP-DLOVCJGASA-N Phe-Ala-Ser Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O UHRNIXJAGGLKHP-DLOVCJGASA-N 0.000 description 1
- UEEVBGHEGJMDDV-AVGNSLFASA-N Phe-Asp-Gln Chemical compound NC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 UEEVBGHEGJMDDV-AVGNSLFASA-N 0.000 description 1
- OPEVYHFJXLCCRT-AVGNSLFASA-N Phe-Gln-Ser Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(O)=O OPEVYHFJXLCCRT-AVGNSLFASA-N 0.000 description 1
- KYYMILWEGJYPQZ-IHRRRGAJSA-N Phe-Glu-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 KYYMILWEGJYPQZ-IHRRRGAJSA-N 0.000 description 1
- RFEXGCASCQGGHZ-STQMWFEESA-N Phe-Gly-Arg Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(O)=O RFEXGCASCQGGHZ-STQMWFEESA-N 0.000 description 1
- YTILBRIUASDGBL-BZSNNMDCSA-N Phe-Leu-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC1=CC=CC=C1 YTILBRIUASDGBL-BZSNNMDCSA-N 0.000 description 1
- IEOHQGFKHXUALJ-JYJNAYRXSA-N Phe-Met-Arg Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O IEOHQGFKHXUALJ-JYJNAYRXSA-N 0.000 description 1
- OAOLATANIHTNCZ-IHRRRGAJSA-N Phe-Met-Asp Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)N OAOLATANIHTNCZ-IHRRRGAJSA-N 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- KPDRZQUWJKTMBP-DCAQKATOSA-N Pro-Asp-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1 KPDRZQUWJKTMBP-DCAQKATOSA-N 0.000 description 1
- ZCXQTRXYZOSGJR-FXQIFTODSA-N Pro-Asp-Ser Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O ZCXQTRXYZOSGJR-FXQIFTODSA-N 0.000 description 1
- JFNPBBOGGNMSRX-CIUDSAMLSA-N Pro-Gln-Ala Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(O)=O JFNPBBOGGNMSRX-CIUDSAMLSA-N 0.000 description 1
- HJSCRFZVGXAGNG-SRVKXCTJSA-N Pro-Gln-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1 HJSCRFZVGXAGNG-SRVKXCTJSA-N 0.000 description 1
- PULPZRAHVFBVTO-DCAQKATOSA-N Pro-Glu-Arg Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O PULPZRAHVFBVTO-DCAQKATOSA-N 0.000 description 1
- FMLRRBDLBJLJIK-DCAQKATOSA-N Pro-Leu-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1 FMLRRBDLBJLJIK-DCAQKATOSA-N 0.000 description 1
- GMJDSFYVTAMIBF-FXQIFTODSA-N Pro-Ser-Asp Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O GMJDSFYVTAMIBF-FXQIFTODSA-N 0.000 description 1
- BGWKULMLUIUPKY-BQBZGAKWSA-N Pro-Ser-Gly Chemical compound OC(=O)CNC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1 BGWKULMLUIUPKY-BQBZGAKWSA-N 0.000 description 1
- ITUDDXVFGFEKPD-NAKRPEOUSA-N Pro-Ser-Ile Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O ITUDDXVFGFEKPD-NAKRPEOUSA-N 0.000 description 1
- QKDIHFHGHBYTKB-IHRRRGAJSA-N Pro-Ser-Phe Chemical compound N([C@@H](CO)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C(=O)[C@@H]1CCCN1 QKDIHFHGHBYTKB-IHRRRGAJSA-N 0.000 description 1
- FDMCIBSQRKFSTJ-RHYQMDGZSA-N Pro-Thr-Leu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O FDMCIBSQRKFSTJ-RHYQMDGZSA-N 0.000 description 1
- IIRBTQHFVNGPMQ-AVGNSLFASA-N Pro-Val-Lys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@@H]1CCCN1 IIRBTQHFVNGPMQ-AVGNSLFASA-N 0.000 description 1
- 241000235527 Rhizopus Species 0.000 description 1
- 241000707216 Scopelarchidae Species 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- MWMKFWJYRRGXOR-ZLUOBGJFSA-N Ser-Ala-Asn Chemical compound N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)CC(N)=O)C)CO MWMKFWJYRRGXOR-ZLUOBGJFSA-N 0.000 description 1
- IDQFQFVEWMWRQQ-DLOVCJGASA-N Ser-Ala-Phe Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O IDQFQFVEWMWRQQ-DLOVCJGASA-N 0.000 description 1
- GXXTUIUYTWGPMV-FXQIFTODSA-N Ser-Arg-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(O)=O GXXTUIUYTWGPMV-FXQIFTODSA-N 0.000 description 1
- QVOGDCQNGLBNCR-FXQIFTODSA-N Ser-Arg-Ser Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(O)=O QVOGDCQNGLBNCR-FXQIFTODSA-N 0.000 description 1
- HVKMTOIAYDOJPL-NRPADANISA-N Ser-Gln-Val Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(O)=O HVKMTOIAYDOJPL-NRPADANISA-N 0.000 description 1
- BRGQQXQKPUCUJQ-KBIXCLLPSA-N Ser-Glu-Ile Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O BRGQQXQKPUCUJQ-KBIXCLLPSA-N 0.000 description 1
- GRSLLFZTTLBOQX-CIUDSAMLSA-N Ser-Glu-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)N GRSLLFZTTLBOQX-CIUDSAMLSA-N 0.000 description 1
- MIJWOJAXARLEHA-WDSKDSINSA-N Ser-Gly-Glu Chemical compound OC[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCC(O)=O MIJWOJAXARLEHA-WDSKDSINSA-N 0.000 description 1
- OQPNSDWGAMFJNU-QWRGUYRKSA-N Ser-Gly-Tyr Chemical compound OC[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 OQPNSDWGAMFJNU-QWRGUYRKSA-N 0.000 description 1
- DOSZISJPMCYEHT-NAKRPEOUSA-N Ser-Ile-Val Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(O)=O DOSZISJPMCYEHT-NAKRPEOUSA-N 0.000 description 1
- QYSFWUIXDFJUDW-DCAQKATOSA-N Ser-Leu-Arg Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O QYSFWUIXDFJUDW-DCAQKATOSA-N 0.000 description 1
- GJFYFGOEWLDQGW-GUBZILKMSA-N Ser-Leu-Gln Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CO)N GJFYFGOEWLDQGW-GUBZILKMSA-N 0.000 description 1
- VMLONWHIORGALA-SRVKXCTJSA-N Ser-Leu-Leu Chemical compound CC(C)C[C@@H](C([O-])=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]([NH3+])CO VMLONWHIORGALA-SRVKXCTJSA-N 0.000 description 1
- IXZHZUGGKLRHJD-DCAQKATOSA-N Ser-Leu-Val Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(O)=O IXZHZUGGKLRHJD-DCAQKATOSA-N 0.000 description 1
- PMCMLDNPAZUYGI-DCAQKATOSA-N Ser-Lys-Val Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(O)=O PMCMLDNPAZUYGI-DCAQKATOSA-N 0.000 description 1
- BSXKBOUZDAZXHE-CIUDSAMLSA-N Ser-Pro-Glu Chemical compound [H]N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O BSXKBOUZDAZXHE-CIUDSAMLSA-N 0.000 description 1
- XGQKSRGHEZNWIS-IHRRRGAJSA-N Ser-Pro-Tyr Chemical compound N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O XGQKSRGHEZNWIS-IHRRRGAJSA-N 0.000 description 1
- XQJCEKXQUJQNNK-ZLUOBGJFSA-N Ser-Ser-Ser Chemical compound OC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O XQJCEKXQUJQNNK-ZLUOBGJFSA-N 0.000 description 1
- OLKICIBQRVSQMA-SRVKXCTJSA-N Ser-Ser-Tyr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O OLKICIBQRVSQMA-SRVKXCTJSA-N 0.000 description 1
- VGQVAVQWKJLIRM-FXQIFTODSA-N Ser-Ser-Val Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(O)=O VGQVAVQWKJLIRM-FXQIFTODSA-N 0.000 description 1
- HSWXBJCBYSWBPT-GUBZILKMSA-N Ser-Val-Val Chemical compound CC(C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CO)C(C)C)C(O)=O HSWXBJCBYSWBPT-GUBZILKMSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- MQBTXMPQNCGSSZ-OSUNSFLBSA-N Thr-Arg-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)[C@@H](C)O)CCCN=C(N)N MQBTXMPQNCGSSZ-OSUNSFLBSA-N 0.000 description 1
- CQNFRKAKGDSJFR-NUMRIWBASA-N Thr-Glu-Asn Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)N)C(=O)O)N)O CQNFRKAKGDSJFR-NUMRIWBASA-N 0.000 description 1
- CRZNCABIJLRFKZ-IUKAMOBKSA-N Thr-Ile-Asp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H]([C@@H](C)O)N CRZNCABIJLRFKZ-IUKAMOBKSA-N 0.000 description 1
- UYTYTDMCDBPDSC-URLPEUOOSA-N Thr-Ile-Phe Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)NC(=O)[C@H]([C@@H](C)O)N UYTYTDMCDBPDSC-URLPEUOOSA-N 0.000 description 1
- AMXMBCAXAZUCFA-RHYQMDGZSA-N Thr-Leu-Arg Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O AMXMBCAXAZUCFA-RHYQMDGZSA-N 0.000 description 1
- QHUWWSQZTFLXPQ-FJXKBIBVSA-N Thr-Met-Gly Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCSC)C(=O)NCC(O)=O QHUWWSQZTFLXPQ-FJXKBIBVSA-N 0.000 description 1
- WVVOFCVMHAXGLE-LFSVMHDDSA-N Thr-Phe-Ala Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C)C(O)=O WVVOFCVMHAXGLE-LFSVMHDDSA-N 0.000 description 1
- SGAOHNPSEPVAFP-ZDLURKLDSA-N Thr-Ser-Gly Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)NCC(O)=O SGAOHNPSEPVAFP-ZDLURKLDSA-N 0.000 description 1
- IQPWNQRRAJHOKV-KATARQTJSA-N Thr-Ser-Lys Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCCCN IQPWNQRRAJHOKV-KATARQTJSA-N 0.000 description 1
- AAZOYLQUEQRUMZ-GSSVUCPTSA-N Thr-Thr-Asn Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CC(N)=O AAZOYLQUEQRUMZ-GSSVUCPTSA-N 0.000 description 1
- CSNBWOJOEOPYIJ-UVOCVTCTSA-N Thr-Thr-Lys Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(O)=O CSNBWOJOEOPYIJ-UVOCVTCTSA-N 0.000 description 1
- JBBYKPZAPOLCPK-JYJNAYRXSA-N Tyr-Arg-Met Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(O)=O JBBYKPZAPOLCPK-JYJNAYRXSA-N 0.000 description 1
- OEVJGIHPQOXYFE-SRVKXCTJSA-N Tyr-Asn-Asp Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O OEVJGIHPQOXYFE-SRVKXCTJSA-N 0.000 description 1
- JWHOIHCOHMZSAR-QWRGUYRKSA-N Tyr-Asp-Gly Chemical compound OC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 JWHOIHCOHMZSAR-QWRGUYRKSA-N 0.000 description 1
- GFJXBLSZOFWHAW-JYJNAYRXSA-N Tyr-His-Glu Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCC(O)=O)C(O)=O GFJXBLSZOFWHAW-JYJNAYRXSA-N 0.000 description 1
- KSCVLGXNQXKUAR-JYJNAYRXSA-N Tyr-Leu-Glu Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O KSCVLGXNQXKUAR-JYJNAYRXSA-N 0.000 description 1
- FWOVTJKVUCGVND-UFYCRDLUSA-N Tyr-Met-Phe Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)NC(=O)[C@H](CC2=CC=C(C=C2)O)N FWOVTJKVUCGVND-UFYCRDLUSA-N 0.000 description 1
- MNWINJDPGBNOED-ULQDDVLXSA-N Tyr-Pro-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CC1=CC=C(O)C=C1 MNWINJDPGBNOED-ULQDDVLXSA-N 0.000 description 1
- MQGGXGKQSVEQHR-KKUMJFAQSA-N Tyr-Ser-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 MQGGXGKQSVEQHR-KKUMJFAQSA-N 0.000 description 1
- PQPWEALFTLKSEB-DZKIICNBSA-N Tyr-Val-Glu Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O PQPWEALFTLKSEB-DZKIICNBSA-N 0.000 description 1
- SLLKXDSRVAOREO-KZVJFYERSA-N Val-Ala-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](C(C)C)N)O SLLKXDSRVAOREO-KZVJFYERSA-N 0.000 description 1
- BWVHQINTNLVWGZ-ZKWXMUAHSA-N Val-Cys-Asp Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(=O)O)C(=O)O)N BWVHQINTNLVWGZ-ZKWXMUAHSA-N 0.000 description 1
- CELJCNRXKZPTCX-XPUUQOCRSA-N Val-Gly-Ala Chemical compound CC(C)[C@H](N)C(=O)NCC(=O)N[C@@H](C)C(O)=O CELJCNRXKZPTCX-XPUUQOCRSA-N 0.000 description 1
- WFENBJPLZMPVAX-XVKPBYJWSA-N Val-Gly-Glu Chemical compound CC(C)[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCC(O)=O WFENBJPLZMPVAX-XVKPBYJWSA-N 0.000 description 1
- LAYSXAOGWHKNED-XPUUQOCRSA-N Val-Gly-Ser Chemical compound CC(C)[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O LAYSXAOGWHKNED-XPUUQOCRSA-N 0.000 description 1
- IJGPOONOTBNTFS-GVXVVHGQSA-N Val-Lys-Glu Chemical compound [H]N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O IJGPOONOTBNTFS-GVXVVHGQSA-N 0.000 description 1
- HJSLDXZAZGFPDK-ULQDDVLXSA-N Val-Phe-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](C(C)C)N HJSLDXZAZGFPDK-ULQDDVLXSA-N 0.000 description 1
- KISFXYYRKKNLOP-IHRRRGAJSA-N Val-Phe-Ser Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(=O)O)N KISFXYYRKKNLOP-IHRRRGAJSA-N 0.000 description 1
- BGXVHVMJZCSOCA-AVGNSLFASA-N Val-Pro-Lys Chemical compound CC(C)[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)O)N BGXVHVMJZCSOCA-AVGNSLFASA-N 0.000 description 1
- QSPOLEBZTMESFY-SRVKXCTJSA-N Val-Pro-Val Chemical compound CC(C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(O)=O QSPOLEBZTMESFY-SRVKXCTJSA-N 0.000 description 1
- UJMCYJKPDFQLHX-XGEHTFHBSA-N Val-Ser-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](C(C)C)N)O UJMCYJKPDFQLHX-XGEHTFHBSA-N 0.000 description 1
- DLRZGNXCXUGIDG-KKHAAJSZSA-N Val-Thr-Asp Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](C(C)C)N)O DLRZGNXCXUGIDG-KKHAAJSZSA-N 0.000 description 1
- UQMPYVLTQCGRSK-IFFSRLJSSA-N Val-Thr-Gln Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](C(C)C)N)O UQMPYVLTQCGRSK-IFFSRLJSSA-N 0.000 description 1
- HVRRJRMULCPNRO-BZSNNMDCSA-N Val-Trp-Arg Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O)=CNC2=C1 HVRRJRMULCPNRO-BZSNNMDCSA-N 0.000 description 1
- NLNCNKIVJPEFBC-DLOVCJGASA-N Val-Val-Glu Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CCC(O)=O NLNCNKIVJPEFBC-DLOVCJGASA-N 0.000 description 1
- XNLUVJPMPAZHCY-JYJNAYRXSA-N Val-Val-Phe Chemical compound CC(C)[C@H]([NH3+])C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C([O-])=O)CC1=CC=CC=C1 XNLUVJPMPAZHCY-JYJNAYRXSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 108010041407 alanylaspartic acid Proteins 0.000 description 1
- 108010005233 alanylglutamic acid Proteins 0.000 description 1
- 108010047495 alanylglycine Proteins 0.000 description 1
- 108010087924 alanylproline Proteins 0.000 description 1
- 150000001413 amino acids Chemical group 0.000 description 1
- 230000002052 anaphylactic effect Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 108010001271 arginyl-glutamyl-arginine Proteins 0.000 description 1
- 108010084758 arginyl-tyrosyl-aspartic acid Proteins 0.000 description 1
- 108010062796 arginyllysine Proteins 0.000 description 1
- 108010010430 asparagine-proline-alanine Proteins 0.000 description 1
- 108010038633 aspartylglutamate Proteins 0.000 description 1
- 108010047857 aspartylglycine Proteins 0.000 description 1
- 108010068265 aspartyltyrosine Proteins 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000003766 bioinformatics method Methods 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- RNFNDJAIBTYOQL-UHFFFAOYSA-N chloral hydrate Chemical compound OC(O)C(Cl)(Cl)Cl RNFNDJAIBTYOQL-UHFFFAOYSA-N 0.000 description 1
- 229960002327 chloral hydrate Drugs 0.000 description 1
- KDLRVYVGXIQJDK-AWPVFWJPSA-N clindamycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@H](C)Cl)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 KDLRVYVGXIQJDK-AWPVFWJPSA-N 0.000 description 1
- 229960002227 clindamycin Drugs 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 238000004042 decolorization Methods 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 108010085059 glutamyl-arginyl-proline Proteins 0.000 description 1
- 108010042598 glutamyl-aspartyl-glycine Proteins 0.000 description 1
- 108010055341 glutamyl-glutamic acid Proteins 0.000 description 1
- 108010008237 glutamyl-valyl-glycine Proteins 0.000 description 1
- 108010049041 glutamylalanine Proteins 0.000 description 1
- VPZXBVLAVMBEQI-UHFFFAOYSA-N glycyl-DL-alpha-alanine Natural products OC(=O)C(C)NC(=O)CN VPZXBVLAVMBEQI-UHFFFAOYSA-N 0.000 description 1
- XBGGUPMXALFZOT-UHFFFAOYSA-N glycyl-L-tyrosine hemihydrate Natural products NCC(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 XBGGUPMXALFZOT-UHFFFAOYSA-N 0.000 description 1
- 108010066198 glycyl-leucyl-phenylalanine Proteins 0.000 description 1
- 108010082286 glycyl-seryl-alanine Proteins 0.000 description 1
- 108010037850 glycylvaline Proteins 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 108010025306 histidylleucine Proteins 0.000 description 1
- 108010085325 histidylproline Proteins 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000001433 inducive effect Effects 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 108010044374 isoleucyl-tyrosine Proteins 0.000 description 1
- 108010034529 leucyl-lysine Proteins 0.000 description 1
- 108010073472 leucyl-prolyl-proline Proteins 0.000 description 1
- 108010000761 leucylarginine Proteins 0.000 description 1
- 108010091871 leucylmethionine Proteins 0.000 description 1
- 108010057821 leucylproline Proteins 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 108010003700 lysyl aspartic acid Proteins 0.000 description 1
- 108010025153 lysyl-alanyl-alanine Proteins 0.000 description 1
- 108010009298 lysylglutamic acid Proteins 0.000 description 1
- 108010017391 lysylvaline Proteins 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 108010005942 methionylglycine Proteins 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 108010073025 phenylalanylphenylalanine Proteins 0.000 description 1
- 244000000003 plant pathogen Species 0.000 description 1
- 238000012257 pre-denaturation Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008261 resistance mechanism Effects 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 108010069117 seryl-lysyl-aspartic acid Proteins 0.000 description 1
- 108010071207 serylmethionine Proteins 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 108010061238 threonyl-glycine Proteins 0.000 description 1
- 108010005834 tyrosyl-alanyl-glycine Proteins 0.000 description 1
- 108010009962 valyltyrosine Proteins 0.000 description 1
- 230000017260 vegetative to reproductive phase transition of meristem Effects 0.000 description 1
- 230000001018 virulence Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 108010027345 wheylin-1 peptide Proteins 0.000 description 1
- 238000012070 whole genome sequencing analysis Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8201—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
- C12N15/8202—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation by biological means, e.g. cell mediated or natural vector
- C12N15/8205—Agrobacterium mediated transformation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
- C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
- C12N15/8279—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
- C12N15/8281—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance for bacterial resistance
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
- Y02A40/10—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in agriculture
- Y02A40/146—Genetically Modified [GMO] plants, e.g. transgenic plants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Botany (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The invention discloses a ralstonia solanacearum effect protein RipXV as well as a coding gene and application thereof. The ralstonia solanacearum effect protein RipXVThe amino acid sequence of (A) is shown as SEQ ID No.2, and the coding gene thereofRipXVThe nucleotide sequence of (A) is shown in SEQ ID No. 1. Transient overexpression in Nicotiana benthamianaRipXVGene, which can induce plant cell death. Construction by homologous recombination△ripXVThe mutant strain, inoculated peanut, shows enhanced pathogenicity, and shows that RipXV is probably a nontoxic effector protein and plays an important role in the pathogenic process of peanut. The target protein AhRFL1 of RipXV is screened from the cDNA library of peanuts induced by ralstonia solanacearum by a yeast two-hybrid technology. The invention has important significance for analyzing the molecular mechanism of the interaction between the ralstonia solanacearum and the host and establishing a comprehensive control technical strategy of the plant bacterial wilt.
Description
Technical Field
The invention relates to the field of plant disease control research, in particular to a peanut ralstonia solanacearum effect protein RipXV, a coding gene thereof, and potential value and application prospect in plant bacterial wilt.
Background
Ralstonia solanacearum (L.), (L.)Ralstonia solanacearum) The caused bacterial wilt is one of important plant diseases in the world. The pathogenic bacteria have the characteristics of wide host range, rich physiological race, wide geographical distribution, quick pathogenic variation, various disease conditions, difficult control and the like, and the caused plant diseases cause huge economic loss. At present, the infection and pathogenic mechanism of the ralstonia solanacearum are not completely clear, so that starting from the pathogenic mechanism of ralstonia solanacearum, the search of an effective action target is of great importance for the prevention and treatment of diseases. The III type secretion system is a pathogenicity determining factor of ralstonia solanacearum, and the ralstonia solanacearum utilizes a large amount of effector proteins injected into host cells to activate or inhibit the defense reaction of the host, thereby causing host diseasesOr inducing the non-host plant to generate a hypersensitivity reaction.
Plant pathogens, when infecting host plants, secrete a class of proteins, called effector proteins, that interact with the host plant R gene product to stimulate the plant's immune system. The gene encoding the pathogen effector inducing R gene mediated resistance is defined as the Avr gene. The effector proteins include toxic proteins and non-toxic proteins, and the toxic proteins are necessary proteins for completely exerting toxicity of pathogenic bacteria entering host cells; non-toxic proteins are proteins that can be recognized directly or indirectly by plants and trigger allergic reactions. Most effector proteins can change the cell structure and function of a host and accelerate the infection of pathogenic bacteria, so that R proteins capable of specifically recognizing different effector proteins are evolved by plants. The interaction of plants with pathogenic bacteria is controlled by specific interactions between the avr (avirulence) gene of the pathogen and the allele of the corresponding disease resistance (R) gene of the plant, i.e. "gene-gene" interactions. In the model, a specific receptor coded by a plant disease-resistant gene recognizes a nontoxic gene product of pathogenic bacteria or a metabolite generated by exciton-mediated catalytic activity, and further triggers a defense reaction of the plant. This model serves to illustrate the specific recognition of the pathogenic Avr protein by the plant R protein, where the former is the ligand for the latter. Although these models provide a simple model parallel to the immune system, the relationships they suggest remain poorly demonstrated, and only a few examples are currently available to demonstrate direct interactions between the R protein and its cognate Avr protein.
Based on the result of the whole genome sequence analysis of the early-stage ralstonia solanacearum RS-P.362200 of the subject group, the experiment obtains an effect protein RipXV of a III type secretion system through bioinformatics analysis, and constructs an over-expression vector to generate strong anaphylactic necrosis reaction through agrobacterium-mediated transient expression of Nicotiana benthamiana. Construction by homologous recombination△RipXVThe mutant strain and inoculated host can obviously enhance the pathogenicity of ralstonia solanacearum, and the RipXV is possibly an avirulence gene and plays a key role in the interaction process of the ralstonia solanacearum and plants. Simultaneously, NBS-LRR disease-resistant protein AhRFL of RipXV interaction in host is screened by yeast double-hybrid1, the AhRFL1 is presumed to be possibly involved in the defense reaction of a host to ralstonia solanacearum and can provide gene resources for the genetic improvement of bacterial wilt resistance of plants. The method is less in interaction research between ralstonia solanacearum and a host at present, and the method starts from ralstonia solanacearum effect protein and host target protein thereof, researches the interaction between RipXV and AhRFL1, provides a new thought for disclosing the pathogenic mechanism and preventing and treating ralstonia solanacearum, and has important scientific significance.
Disclosure of Invention
The invention aims to provide the peanut ralstonia solanacearum effect protein RipXV and the coding gene and application thereof, provides a theoretical basis for ralstonia solanacearum pathogenesis and peanut bacterial wilt resistance, and has important application prospect.
In order to realize the purpose, the invention adopts the following technical scheme:
the invention firstly provides a ralstonia solanacearum effect protein RipXV, and the amino acid sequence of the ralstonia solanacearum effect protein RipXV is shown in SEQ ID NO. 2.
The invention further provides a gene for coding the ralstonia solanacearum effect protein RipXV, and the gene isRipXVThe nucleotide sequence is shown in SEQ ID NO. 1.
The invention also provides an overexpression vector containing the ralstonia solanacearum effector protein RipXV, and the construction method of the overexpression vector comprises the following steps: gate entry vector pDONR 207-based construction by BP reaction based on Gataway systemRipXVConstruction of 35S promoter-driven plant expression vector pK7WG2.0-RipXVThe expression vector is the overexpression vector containing the ralstonia solanacearum effector protein RipXV.
The invention also provides a knockout vector containing the ralstonia solanacearum effector protein RipXV, and the construction method of the knockout vector comprises the following steps: cloning based on the whole gene sequence of ralstonia solanacearum RS-P.362200RipXVAn upstream 657 bp fragment (U) and a downstream 643 bp fragment (D) are used for constructing a knockout vector pK18mobSacB-U-D by an enzyme digestion connection method.
The invention also provides a anaplerotic vector containing the ralstonia solanacearum effect protein RipXV,the construction method of the anaplerotic vector comprises the following steps: cloning an upstream 657 bp fragment (U) according to the complete gene sequence of the pseudomonas solanacearum RS-P.362200,RipXV(1062 bp) and a downstream 643 bp fragment (D), and constructing a complementation vector pK18mobSacB-U-RipXV-D by an enzyme digestion ligation method.
The invention also provides a protein interacting with the peanut ralstonia solanacearum effector protein RipXV, wherein the protein is NBS-LRR disease-resistant protein AhRFL1, the nucleotide sequence of the protein is shown as SEQ ID No.3, and the protein sequence is shown as SEQ ID No. 4. AhRFL1 was obtained based on a yeast two-hybrid screen: construction of the bait vector PGBKT7-RipXVAnd further screening to obtain the interactive protein of RipXV according to the mixed cDNA library of the rhizopus inducive roots and leaves of the ralstonia solanacearum.
The invention also provides application of the ralstonia solanacearum effector protein RipXV in stimulating plant defense reaction and anaphylactic reaction and/or stimulating plant disease-resistant gene expression as an effector protein.
The invention also provides the ralstonia solanacearum effect protein geneRipXVThe application in culturing transgenic engineering bacteria with enhanced pathogenicity to flowers.
Furthermore, the method for cultivating the transgenic engineering bacteria with enhanced pathogenicity to the peanuts is to use the original strainsRipXVKnocking out genes, and screening to obtain transgenic engineering bacteria with enhanced pathogenicity to the peanut; the starting strain is ralstonia solanacearum (A)Ralstonia solanacearum)。
The invention has the beneficial effects that:
through the whole genome sequencing analysis of ralstonia solanacearum Rs-P.362200, the application predicts a triple-type effector protein RipXV and instantaneously over-expresses the coding gene of the triple-type effector protein RipXV on Nicotiana benthamianaRipXVA strong allergic necrosis reaction is induced. Knock-outRipXVThe pathogenicity of the ralstonia solanacearum can be obviously enhanced after the gene is obtained, and the first report that RipXV influences the pathogenicity of the ralstonia solanacearum is reported. The invention further screens host target NBS-LRR disease-resistant protein AhRFL1 of RipXV for the first time through yeast two-hybrid. The research result of the invention has the effects of disclosing the pathogenic mechanism of ralstonia solanacearum on the peanuts and the bacterial wilt resistance mechanism of the peanutsImportant scientific significance.
Drawings
FIG. 1: pK7WG2.0-RipXVSchematic diagram of overexpression vector construction.
FIG. 2: a schematic diagram of RipXV knockout and anaplerosis strains is constructed based on a homologous recombination method.△RipXVIs a knockout mutant of the effector protein RipXV,C△RipXVis an effector protein△RipXVThe anaplerotic strain of (1).
FIG. 3: RipXV knockout and complementation strain construction PCR amplification electrophoresis gel running results. WT shows the result of PCR amplification of a wild type Ralstonia solanacearum strain,△RipXVshows the PCR amplification result of the knockout strain,C△RipXVthe results of PCR amplification of the complemented strain are shown, and "-" shows a negative control.
FIG. 4 is a schematic view of: transient overexpression of ralstonia effect protein in Nicotiana benthamiana leavesRipXVThe gene causes intense cell necrosis. HR reaction results show transient overexpressionRipXVCauses intense allergic death in nicotiana benthamiana leaves; DAB staining result displayRipXVCause HR reaction to generate a large amount of H 2 O 2 Trypan blue staining results showRipXVCausing the HR reaction to produce large amounts of calluses.
FIG. 5:RipXVthe mutant and complementing strains of (a) inoculate a postnatal phenotype.
FIG. 6: the interaction between RipXV and AhRFL1 in yeast is verified. The positive control was pGBKT7-53+ pGADT7-T and the negative control was pGBKT7-Lam + PGADT 7-T.
Detailed Description
[ example 1 ] constructionRipXVOverexpression vectors
Inquiring according to the whole genome sequence of ralstonia solanacearum Rs-P.362200RipXVCDS sequence of full-length gene, design of specific primer: (RipXV-attB1-F:5’-GGGGACAAGTTTGTACAAAAAAGCA
GGCTTCATGAAAAGATTTATGAGG-3’,RipXV-attB 2-R: 5'-GGGGACCACTTTGTACAAGAAAGCTGGGTCTCGCTCAATAGCTTTTC-3') performing PCR amplification using Ralstonia arachidicola genomic DNA as a template, using PrimeSTAR from Takara ® Max is used for amplification, and the PCR reaction system is as follows: 1 μ L of DNA template, 10 μ L of 2 XPrimeSTAR ® Max, 0.5 muL of each forward primer and reverse primer, and water is supplemented to 20 muL. The reaction conditions are as follows: pre-denaturation at 95 ℃ for 5 min; 30 cycles of 95 ℃ for 30 s, 60 ℃ for 30 s, and 72 ℃ for 1 min. Carrying out agarose gel electrophoresis detection on a PCR product, then cutting, purifying and recovering gel, and carrying out no-load connection on a target gene fragment and pDONR207 to carry out BP reaction:RipXVthe PCR product of 1 muL, pDONR207 no-load 1 muL, BP enzyme 0.25 muL, 25 ℃ connection overnight, the connection product is transformed into Escherichia coli DH5 alpha competent cells, positive clones are screened for sequencing, correctly read-through clone extraction plasmids are constructed, and an entry vector pDONR207-RipXV. The entry vector plasmid and the over-expression vector pK7WG2.0 were subjected to an LR reaction: pDONR207-RipXVPlasmid 1 uL, pEarley Gate201 no-load 1 uL, LR enzyme 0.25 uL, 25 ℃ connection overnight, transformation of Escherichia coli, verification of positive clone, construction of 35S CaMV promoter driven overexpression vector pK7WG2.0-RipXV. The construction process of the overexpression vector is schematically shown in FIG. 1.
[ example 2 ]△RipXVDeletion mutants andC△RipXVconstruction of a complementation vector
Finding out an upstream 657 bp sequence U and a downstream 643 bp sequence D of RipXV according to Ralstonia solanacearum Rs-P.362200, designing specific primers RipXV-1-F (5'-CGGAATTCAGCTTCCCATCGAACACTG-3'), RipXV-1-R (5'-CGGGATCCGATAGACAATCCTTGAATTTTC-3'), RipXV-2-F (5'-CGGGATCCGTATGATCTGCTCAGAGTCG-3') and RipXV-2-R (5'-CCAAGCTTTCAACATCAAGGCGATCC-3'), carrying out PCR amplification by taking Ralstonia arachidicola genome DNA as a template, and carrying out amplification by adopting PCR premix of Kangji company, wherein the PCR reaction system is as follows: 1 muL of genome DNA template, 5 muL of PCR premix, 0.5 muL of forward and reverse primers and 3 muL of water. The reaction conditions are as follows: 5 min at 94 ℃; 30 s at 94 ℃, 30 s at 60 ℃,1 min at 72 ℃ and 28 cycles; preserving at 72 deg.C for 10 min and 25 deg.C. And (3) detecting the PCR product by agarose gel electrophoresis, purifying and recovering the PCR product after no impurity band. The target fragment and the empty pK18mobsacb are respectively cut and recovered by restriction enzymes EcoRI, BamHI and HindIII, and U and D are respectively connected to the pK18mobsacb vector by T4 ligase under the following connection conditions: t4 ligase 2 μ L, T4 buffer 1 μ L, pK18mobsacb 1 μ L (100 ng), U/D2 μ L (100 ng), H 2 O4. mu.L, 16 ℃ ligation overnight.The ligation product is transformed into escherichia coli, positive cloning is verified by PCR,RipXVthe construction of the knockout vector pK18mobsacb-U-D is completed, and the schematic diagram of the vector construction process is shown in the left figure of FIG. 2.
The construction method of the anaplerotic vector comprises the following steps: according to the whole genome sequence of ralstonia solanacearum Rs-P.362200, specific primers are designed, ralstonia solanacearum genome DNA is used as a template for PCR amplification (construction of a PCR reaction system and a knockout vector), and meanwhile, 2362 bp fragments (CRipXV-XhoI-F: 5'-ATTACTCGAGTCGCCTACGCTACAATCTCCTG-3', CRipXV-BamHI-R: 5'-ACCAGGATCCTCATCGCTCAATAGCTTTTCTG-3') which are totally included in upstream 657 bp, (U), RipXV (1062 bp) and downstream 643 bp (D) are cloned. The target fragment and the pK18mobsacb were recovered by digestion with restriction enzymes XhoI and BamHI, respectively, and U-RipXV-D was ligated to the pK18mobsacb vector using T4 ligase (ligation conditions were as above). The ligation product is transformed into Escherichia coli, positive cloning is verified by PCR, the RipXV complementation vector pK18mobSacB-U-RipXV-D is constructed, and the schematic diagram of the vector construction process is shown in the right graph in figure 2.
[ example 3 ] Triparental conjugation method△RipXVKnock-out mutations andC△RipXVanaplerotic strain
The construction method of the mutant strain and the anaplerotic strain is mainly carried out by adopting a three-parent combination method, selecting the host bacterium, namely the pseudomonas solanacearum, and monoclonally culturing the host bacterium pseudomonas solanacearum in a 4 mL BG liquid culture medium (containing 100 mg/L polymyxin B), and culturing the host bacterium in a constant temperature shaking table at 28 ℃ until the thallus concentration OD is up to 600 When =0.6, all the cells were collected in a 2 mL EP tube; selecting helper MT616, culturing the single clone in an LB liquid culture medium (containing 34 mg/L clindamycin) of 4 mL in a constant temperature shaking table at 37 ℃, and collecting all thalli by using an EP (enhanced EP) tube of 2 mL when the thalli concentration OD600= 1.0; the donor bacteria pK18mobSacB-U-RipXV-D or pK18mobSacB-U-D were selected and monoclonal to 4 mL LB liquid medium (containing 50 mg/L kanamycin), cultured in a shaker at 37 ℃ until OD of the bacterial concentration 600 When =2.0, all the cells were collected in a 2 mL EP tube; centrifuging the three thalli at 5000 rpm for 5 min, washing the collected thalli twice with sterile water, and then resuspending the thalli with the sterile water; the cell concentration OD was measured by a spectrophotometer 600 Adjusting the temperature to 1.0; then the host bacterium is culturedRalstonia arachidicola, helper MT616, donor pK18mobSacB-U-RipXV-D or pK18mobSacB-U-D were as follows 2: 1:1, uniformly mixing; and centrifugally collecting the thallus, resuspending the thallus in 50 muL of sterile water, uniformly dropping the thallus on a BG flat plate by using a pipette gun, and inversely culturing the flat plate in a constant-temperature incubator at 28 ℃ after the flat plate bacterial liquid is dried, and inducing for 2-3 d. The mixed bacteria on the plate is scraped and suspended by 100 muL sterile water, a BG plate (containing 100 mg/L polymyxin B and 50 mg/L kanamycin) is uniformly coated (a small amount of ralstonia solanacearum bacterial liquid is streaked at the edge of the plate to be used as negative control), and the plate is placed in a constant temperature incubator at the temperature of 28 ℃ for two days; picking the ralstonia solanacearum with good growth condition on the plate, extracting genome DNA, and amplifying the ralstonia solanacearum by using specific primers RipXV-1-F and RipXV-2-R, wherein if the amplified bands are consistent with the sizes of the designed fragments (two bands, one is at 1.28 kb and the other is at 2.92 kb), the carrier is successfully transferred into the ralstonia solanacearum.
Selecting 5-6 ralstonia solanacearum with good growth vigor and consistent PCR strip size to perform streak culture on a BG (PB + Kan) plate for 1-2 days (a little of ralstonia solanacearum bacterial liquid is streaked at the edge of the plate to be used as negative control), and selecting the ralstonia solanacearum to perform streak culture on the BG plate for 1 d. Well-growing ralstonia solanacearum is picked and streaked on BG and BGS plates respectively (colonies containing sac vector do not grow or grow slowly on the sucrose-containing medium). After 1 d, selecting the ralstonia solanacearum which grows well on the BG plate but does not grow or grows slowly on the BGS plate, shaking the ralstonia solanacearum for 5-6 h at 28 ℃, and then coating 100 mu L of the ralstonia solanacearum on a BGS flat plate for culturing for 1-2 d. After 2 days, well-growing ralstonia solanacearum was streaked on BG and BG plates (containing 100 mg/L polymyxin B and 50 mg/L kanamycin) for overnight culture (with plates with grids, first with antibiotic, and then with BG plates). Bacterial wilt cells which do not grow on BG plates (containing 100 mg/L polymyxin B and 50 mg/L kanamycin) were picked, genomic DNA was extracted, and amplified with specific primers RipXV-1-F and RipXV-2-R, and bacterial wilt cells were used as a positive control. And selecting pseudomonas solanacearum without bands in PCR (polymerase chain reaction) for genome extraction, and verifying by using a specific primer.
Mutant and complementation strains of RipXV were obtained by the above method, and PCR identification of the primers specific for the mutant and complementation strains is shown in FIG. 3.
Example 4 transient overexpression of RipXV coding Gene in Nicotiana benthamiana leaves
And (3) transforming the constructed RipXV overexpression plasmid into Agrobacterium tumefaciens GV3101, culturing for 2 d in an incubator at 28 ℃, selecting well-growing clones, adding the clones into a corresponding antibiotic culture medium, placing the corresponding antibiotic culture medium into a shaking table for shake culture, setting the temperature at 28 ℃, the rotating speed at 250 rpm, performing overnight culture, and verifying whether the transformation is successful by PCR. Positive clones verified to be correct were added to 50 mL of medium and shaken until OD was measured 600 The value was 0.5. Placing into a centrifuge, centrifuging at 4000 rpm for 10 min, re-suspending with MES buffer solution, and separating OD 600 Adjusting to 0.7-0.8, and incubating in an incubator at 28 ℃ for 2 h. Healthy Nicotiana benthamiana in the 5-6 leaf stage is selected, 3 strains are used as an experimental group, 3 strains are used as a control group, the penultimate leaf and the third leaf of the plant are selected, a 1 mL syringe needle is used for puncturing the leaves, agrobacterium liquid is injected at the punctured position through an agrobacterium infiltration method, and the injection area is a circle with the diameter of 1 cm. After incubation in the greenhouse at 25 ℃ for 48 h, the tobacco phenotype was recorded by observing the photographs. After 48 h of transient overexpression in Nicotiana benthamiana leaves, infected plants were stained with 3, 3' -Diaminobenzidine (DAB) and lactol-ethanol-trypan blue. The injected Nicotiana benthamiana leaves are placed in 1 mg/mL DAB solution for incubation at room temperature overnight, boiled in 3:1:1 ethanol/lactic acid/glycerol solution for 5 min, and then placed in absolute ethanol for decolorization. Cell death was detected using trypan blue staining, the injected leaves were boiled in trypan blue solution for 2 minutes, trypan blue solution (10 mL lactic acid, 10 mL glycerol, 10 g phenol, 30mL absolute ethanol and 10 mg trypan blue), stained overnight at room temperature, transferred to chloral hydrate solution (2.5 g/mL) and boiled for 20 minutes to remove the stain. The staining results were observed under an optical microscope. Transient expression, as shown in FIG. 4RipXVCan make the Nicotiana benthamiana generate strong allergic necrosis reaction, and DAB staining results show transient overexpressionRipXVThe gene can release a large amount of active oxygen, and trypan blue staining results show that the transient overexpression is realizedRipXVGenes can produce large amounts of calluses.
Example 5 Effect of RipXV on the virulence of Ralstonia solanacearum
Wild type strain (WT), mutant strain, and anaplerotic strain were treated with 15 mL BG (100 mg/L PB) in a constant temperature shaker at 28 ℃ at 250 rpm + ) And (5) culturing. OD to be measured 600 And when the number is not less than 0.4, inoculating inverted two and inverted three functional leaves of the peanut by a leaf cutting inoculation method, and observing and recording the growth condition of the peanut plant after inoculation 7 days later. The phenotype of the bacterial wilt after inoculation and flowering is shown in FIG. 5, the wild type strain (WT) shows disease resistance 7 days after inoculation of peanut Guangdong oil for resisting bacterial wilt 92, and the mutant△RipXVThe leaf blades of the peanut variety Guangdong oil resistant to the bacterial wilt appear withered 7 days after the bacterial strain is inoculated with 92 days of the Guangdong oil, the plant shows typical symptoms of the bacterial wilt, and the leaf blades of the peanut variety Guangdong oil resistant to the bacterial wilt recover the disease resistance 7 days after the replanting bacterial strain C delta RipXV is inoculated with 92 days of the Guangdong oil resistant to the bacterial wilt.
Example 6 screening and verification of Ralstonia solanacearum Effector protein RipXV interaction target protein
RipXV-BD-NcoI-F (5'-AGGACCATGGACCATGAAAAGATTTATGAG-3') and RipXV-BD-BamHI-R (5'-ATTAGGATCCTCATCGCTCAATAGCTTTTC-3') were used as primers and pDONR207-RipXV plasmid was used as a template to amplify a PCR product of RipXV, the PCR product and a bait vector PGBKT7 were digested simultaneously with NcoI and BamHI, and after the target band was recovered, RipXV was ligated to a PGBKT7 vector using T4 DNA ligase (ligation conditions were the same as above). The ligation product was transformed into E.coli, positive clones were verified by PCR and sent to the sequencer to verify, obtaining the bait vector pGBKT 7-RipXV. The self-activation and toxicity detection of the bait vector are verified by pGBKT7-RipXV transformation yeast Y2H Gold yeast strain, the self-activation phenomenon is avoided, and the subsequent screening library test can be carried out. Preparing competent cells of pGBKT7-RipXV yeast positive clones, transforming root and leaf mixed cDNA library plasmids induced by ralstonia solanacearum with peanuts, coating SD/-His/-Leu/-Trp plates with transformed thalli, selecting the clone points SD/-Ade/-His/-Leu/-Trp plates which grow normally on the SD/-His/-Leu/-Trp plates, and taking the clones which turn blue on the four-deficiency plates after 2-3 d as candidate positive clones. Plasmids of candidate positive clones were extracted, verified by PCR, and the PCR products were sequenced by the company and aligned to query the coding sequence of the interacting target protein AhRFL1 in PGR (http:// peanutgr. Cloning the CDS sequence of AhRFL1 full-length gene into PGADT7 vectorCo-transforming PGADT7-AhRFL1 and PGBKT7-RipXV plasmid into Y2H yeast competent cell, coating SD/-Leu/-Trp plate, selecting clone, shaking, and performing cell culture according to the method of 10 0 /10 -1 /10 -2 /10 -3 The bacterial suspension was diluted in gradient, 5. mu.L was applied to SD/-Ade/-His/-Leu/-Trp + X-. alpha. -gal plates, and the colonies became blue after 3 days, indicating that the interaction between RipXV and AhRFL1 existed (FIG. 6).
The above description is only a preferred embodiment of the present invention, and all equivalent changes and modifications made according to the claims of the present invention should be covered by the present invention.
SEQUENCE LISTING
<110> Fujian agriculture and forestry university
<120> peanut ralstonia solanacearum effect protein RipXV and coding gene and application thereof
<130>
<160> 14
<170> PatentIn version 3.3
<210> 1
<211> 1062
<212> DNA
<213> Ralstonia solanacearum)
<400> 1
atgaaaagat ttatgagggc gattggcgta gggtcgagcc gaagcacccg gaccaactac 60
gtagagccgc aagctgatga cgcacctgac tcaaacgcca gttccaattc atcaccggaa 120
aggcctacct tgaggcgctc cccgaaccct gcttttgcga gcctgcctcc gcgcgccaaa 180
gataaggcgg tcgcattgga caattcgttg cgaagaaatt tgaattatat tccatccgat 240
ttggaaaact atgctcgcgc tgccctgaat agggtggagt atactgcgac atcaggcgag 300
atgactgatc ttgatattga aaatattcac catctcgttg gggcatataa tgacagattt 360
tctgggctgc atttaaaaaa tcacgaatcc cctcgatcat ttttcgagga attcatggat 420
tctggggagt ctgtttggcg ttccgtcgtt aggctaagca tgaatgatcg tcatcatgtg 480
gcaatcgatg ttcgagttga tgacgacaag cgaaccatga taataataga gtcggcgctg 540
gcgcataatc ctcgtcagcc aggcgtattt cttcaggggt atgagcagct tagtggtaaa 600
ttggcaagct acgccggaga ggatggcggt atggctgtag tggagttggg ggtgcaaaaa 660
tcgaattacg attgcattat ttactcattg aataactccc ttgctgcata tcaaaagaat 720
gaggtttttg atgaaatgca tgcgagcctg agggcgatag ggaggtgttt cggtaggtac 780
gatgggaagt caactataca aagcggtatc gagcttatcg atggaagcaa agttctgcca 840
gcaatcttct tcaagcatgc acactccaga gcaacaattg atgatgttct tgagaatcaa 900
ccggatcttg agggaagaaa tgtaagtacg ggcagcgaaa atcctcatca aacgttgtcg 960
cagcgagtgc gagatttcag aattgagcga gacgatagag ggtatagcat gtccattgaa 1020
gcatccaggt tgcgaaaaat cagaaaagct attgagcgat ga 1062
<210> 2
<211> 353
<212> PRT
<213> Ralstonia solanacearum)
<400> 2
Met Lys Arg Phe Met Arg Ala Ile Gly Val Gly Ser Ser Arg Ser Thr
1 5 10 15
Arg Thr Asn Tyr Val Glu Pro Gln Ala Asp Asp Ala Pro Asp Ser Asn
20 25 30
Ala Ser Ser Asn Ser Ser Pro Glu Arg Pro Thr Leu Arg Arg Ser Pro
35 40 45
Asn Pro Ala Phe Ala Ser Leu Pro Pro Arg Ala Lys Asp Lys Ala Val
50 55 60
Ala Leu Asp Asn Ser Leu Arg Arg Asn Leu Asn Tyr Ile Pro Ser Asp
65 70 75 80
Leu Glu Asn Tyr Ala Arg Ala Ala Leu Asn Arg Val Glu Tyr Thr Ala
85 90 95
Thr Ser Gly Glu Met Thr Asp Leu Asp Ile Glu Asn Ile His His Leu
100 105 110
Val Gly Ala Tyr Asn Asp Arg Phe Ser Gly Leu His Leu Lys Asn His
115 120 125
Glu Ser Pro Arg Ser Phe Phe Glu Glu Phe Met Asp Ser Gly Glu Ser
130 135 140
Val Trp Arg Ser Val Val Arg Leu Ser Met Asn Asp Arg His His Val
145 150 155 160
Ala Ile Asp Val Arg Val Asp Asp Asp Lys Arg Thr Met Ile Ile Ile
165 170 175
Glu Ser Ala Leu Ala His Asn Pro Arg Gln Pro Gly Val Phe Leu Gln
180 185 190
Gly Tyr Glu Gln Leu Ser Gly Lys Leu Ala Ser Tyr Ala Gly Glu Asp
195 200 205
Gly Gly Met Ala Val Val Glu Leu Gly Val Gln Lys Ser Asn Tyr Asp
210 215 220
Cys Ile Ile Tyr Ser Leu Asn Asn Ser Leu Ala Ala Tyr Gln Lys Asn
225 230 235 240
Glu Val Phe Asp Glu Met His Ala Ser Leu Arg Ala Ile Gly Arg Cys
245 250 255
Phe Gly Arg Tyr Asp Gly Lys Ser Thr Ile Gln Ser Gly Ile Glu Leu
260 265 270
Ile Asp Gly Ser Lys Val Leu Pro Ala Ile Phe Phe Lys His Ala His
275 280 285
Ser Arg Ala Thr Ile Asp Asp Val Leu Glu Asn Gln Pro Asp Leu Glu
290 295 300
Gly Arg Asn Val Ser Thr Gly Ser Glu Asn Pro His Gln Thr Leu Ser
305 310 315 320
Gln Arg Val Arg Asp Phe Arg Ile Glu Arg Asp Asp Arg Gly Tyr Ser
325 330 335
Met Ser Ile Glu Ala Ser Arg Leu Arg Lys Ile Arg Lys Ala Ile Glu
340 345 350
Arg
<210> 3
<211> 1884
<212> DNA
<213> peanut (Arachis hypogaea)
<400> 3
atggttcatg aaggagagcg aattatcaag atggaagagg gtatttctgt cacagatgat 60
tatgattctg gatatttgat gcagttccag tccagagaaa gcactttcga tcaaattttg 120
gaagcactaa aagattgtaa gatctctcag gttgcattgt ctggcatggg tggatcagga 180
aagacaacct tagcaaaaca agtgggtgaa aaggccaagc tgttgaacat cttcaacctt 240
gttgtattcg ttcctgtgac atctactcca agtttcatga agatacaagg tgagatagct 300
gaccaattga gtctcagatt gggagaagaa gctggtctag ctgcaagaca gagaaaaaaa 360
tcaatgacaa gtaaagaact ggttcttata attttggatg atgtgttgga caggctcaac 420
ctggaaaaga tagggatttt taatggttgt aatggattgc agcttagaac catgggtagg 480
cgtatgagct gtaaagtcct catgactaca agtactcaag aagcagtata taggatggga 540
tgccaaccaa gcattaacct gtctttatta actgaaggag aagcttgcga tcttttgagg 600
aagcatgcag acattagtga cggctcccct gaatcaattg ttgaagtagc aaaacaagtt 660
gcgaaacatt gtcatggttt accccttgca agttcagtga ttggatccac tttaagagga 720
aaaactgttg accagtggaa ggaagtatta aaaacaatgc agatgctacc agtgaagagt 780
ttgcaatgtg aagctgacac atctaaattt attcaccaga ttatagaagt aggctatcat 840
gaactgagca ccagagtaac taaaaccata ttcttaatat gtggtttgtt tccaagtggt 900
cgtgatcatg aacatgaagt tctcattgaa gagctgtcac aatatgcaat ccgactaggc 960
tggaggaaag atgaagtgag agcagccatc aatgacctca ttgagtctag tttgctgatg 1020
ctttctgata aaagcaaaga ccatatcata atgagtagtc tggtgcgtga cattgctaga 1080
aagatggttt atgaggatat ccctgccagc aagatggtta atgtttgtga ttacatgttt 1140
gcacaatata atcaggaaga tttccagtgg cgtgtagcat tacatcgact tcttcacttg 1200
ttgtatggca gtgcaaatga gctggcatct tcatcaacga ccaatgcaac atttgctgaa 1260
gagggtcttg aattccaaga tgtgtcgtcc tattcctatc caaaggttgc tacagttcct 1320
aagctatcag ggaaaatggt gaattttaaa aggctgtgtc aggtggacaa atcattcctg 1380
cctctgctca agaaagcgtg tgagaaccac ccccagctga ttcatagcca gaaaaaccac 1440
tctgaaatag taacacaaag cgcctttgat agcttagggc gggtgctgtt tctgttgaaa 1500
aatgttgaga agagggattg ggtgtatctg gaagatgagt tacgtattct ctggaagcag 1560
ttaaacgagt tcaaatttga tttggaatgg ttaagtcctt atgtgaaaga ggtgttctct 1620
accactaaga tcaccaggat tgaagtactt cgggagaaag agaaggattt gaaagacgaa 1680
gctgctaagc tgcgtgcact gcttggagct gcagaggacg aagctgctaa gctgcgtgcc 1740
cggcttgggg ttgttgagga cggagcttct gagctacgcg aacgactcaa ggtgaccgag 1800
aacaaagctg cagatgttag ggctgaagtt gtccgcagag aatctgagat gattgaatct 1860
gcaattgcta ttgttatgga gtaa 1884
<210> 4
<211> 627
<212> PRT
<213> peanut (Arachis hypogaea)
<400> 4
Met Val His Glu Gly Glu Arg Ile Ile Lys Met Glu Glu Gly Ile Ser
1 5 10 15
Val Thr Asp Asp Tyr Asp Ser Gly Tyr Leu Met Gln Phe Gln Ser Arg
20 25 30
Glu Ser Thr Phe Asp Gln Ile Leu Glu Ala Leu Lys Asp Cys Lys Ile
35 40 45
Ser Gln Val Ala Leu Ser Gly Met Gly Gly Ser Gly Lys Thr Thr Leu
50 55 60
Ala Lys Gln Val Gly Glu Lys Ala Lys Leu Leu Asn Ile Phe Asn Leu
65 70 75 80
Val Val Phe Val Pro Val Thr Ser Thr Pro Ser Phe Met Lys Ile Gln
85 90 95
Gly Glu Ile Ala Asp Gln Leu Ser Leu Arg Leu Gly Glu Glu Ala Gly
100 105 110
Leu Ala Ala Arg Gln Arg Lys Lys Ser Met Thr Ser Lys Glu Leu Val
115 120 125
Leu Ile Ile Leu Asp Asp Val Leu Asp Arg Leu Asn Leu Glu Lys Ile
130 135 140
Gly Ile Phe Asn Gly Cys Asn Gly Leu Gln Leu Arg Thr Met Gly Arg
145 150 155 160
Arg Met Ser Cys Lys Val Leu Met Thr Thr Ser Thr Gln Glu Ala Val
165 170 175
Tyr Arg Met Gly Cys Gln Pro Ser Ile Asn Leu Ser Leu Leu Thr Glu
180 185 190
Gly Glu Ala Cys Asp Leu Leu Arg Lys His Ala Asp Ile Ser Asp Gly
195 200 205
Ser Pro Glu Ser Ile Val Glu Val Ala Lys Gln Val Ala Lys His Cys
210 215 220
His Gly Leu Pro Leu Ala Ser Ser Val Ile Gly Ser Thr Leu Arg Gly
225 230 235 240
Lys Thr Val Asp Gln Trp Lys Glu Val Leu Lys Thr Met Gln Met Leu
245 250 255
Pro Val Lys Ser Leu Gln Cys Glu Ala Asp Thr Ser Lys Phe Ile His
260 265 270
Gln Ile Ile Glu Val Gly Tyr His Glu Leu Ser Thr Arg Val Thr Lys
275 280 285
Thr Ile Phe Leu Ile Cys Gly Leu Phe Pro Ser Gly Arg Asp His Glu
290 295 300
His Glu Val Leu Ile Glu Glu Leu Ser Gln Tyr Ala Ile Arg Leu Gly
305 310 315 320
Trp Arg Lys Asp Glu Val Arg Ala Ala Ile Asn Asp Leu Ile Glu Ser
325 330 335
Ser Leu Leu Met Leu Ser Asp Lys Ser Lys Asp His Ile Ile Met Ser
340 345 350
Ser Leu Val Arg Asp Ile Ala Arg Lys Met Val Tyr Glu Asp Ile Pro
355 360 365
Ala Ser Lys Met Val Asn Val Cys Asp Tyr Met Phe Ala Gln Tyr Asn
370 375 380
Gln Glu Asp Phe Gln Trp Arg Val Ala Leu His Arg Leu Leu His Leu
385 390 395 400
Leu Tyr Gly Ser Ala Asn Glu Leu Ala Ser Ser Ser Thr Thr Asn Ala
405 410 415
Thr Phe Ala Glu Glu Gly Leu Glu Phe Gln Asp Val Ser Ser Tyr Ser
420 425 430
Tyr Pro Lys Val Ala Thr Val Pro Lys Leu Ser Gly Lys Met Val Asn
435 440 445
Phe Lys Arg Leu Cys Gln Val Asp Lys Ser Phe Leu Pro Leu Leu Lys
450 455 460
Lys Ala Cys Glu Asn His Pro Gln Leu Ile His Ser Gln Lys Asn His
465 470 475 480
Ser Glu Ile Val Thr Gln Ser Ala Phe Asp Ser Leu Gly Arg Val Leu
485 490 495
Phe Leu Leu Lys Asn Val Glu Lys Arg Asp Trp Val Tyr Leu Glu Asp
500 505 510
Glu Leu Arg Ile Leu Trp Lys Gln Leu Asn Glu Phe Lys Phe Asp Leu
515 520 525
Glu Trp Leu Ser Pro Tyr Val Lys Glu Val Phe Ser Thr Thr Lys Ile
530 535 540
Thr Arg Ile Glu Val Leu Arg Glu Lys Glu Lys Asp Leu Lys Asp Glu
545 550 555 560
Ala Ala Lys Leu Arg Ala Leu Leu Gly Ala Ala Glu Asp Glu Ala Ala
565 570 575
Lys Leu Arg Ala Arg Leu Gly Val Val Glu Asp Gly Ala Ser Glu Leu
580 585 590
Arg Glu Arg Leu Lys Val Thr Glu Asn Lys Ala Ala Asp Val Arg Ala
595 600 605
Glu Val Val Arg Arg Glu Ser Glu Met Ile Glu Ser Ala Ile Ala Ile
610 615 620
Val Met Glu
625
<210> 5
<211> 49
<212> DNA
<213> Artificial sequence
<400> 5
ggggacaagt ttgtacaaaa aagcaggctt catgaaaaga tttatgagg 49
<210> 6
<211> 47
<212> DNA
<213> Artificial sequence
<400> 6
ggggaccact ttgtacaaga aagctgggtc tcgctcaata gcttttc 47
<210> 7
<211> 27
<212> DNA
<213> Artificial sequence
<400> 7
cggaattcag cttcccatcg aacactg 27
<210> 8
<211> 30
<212> DNA
<213> Artificial sequence
<400> 8
cgggatccga tagacaatcc ttgaattttc 30
<210> 9
<211> 28
<212> DNA
<213> Artificial sequence
<400> 9
cgggatccgt atgatctgct cagagtcg 28
<210> 10
<211> 26
<212> DNA
<213> Artificial sequence
<400> 10
ccaagctttc aacatcaagg cgatcc 26
<210> 11
<211> 32
<212> DNA
<213> Artificial sequence
<400> 11
attactcgag tcgcctacgc tacaatctcc tg 32
<210> 12
<211> 32
<212> DNA
<213> Artificial sequence
<400> 12
accaggatcc tcatcgctca atagcttttc tg 32
<210> 13
<211> 30
<212> DNA
<213> Artificial sequence
<400> 13
aggaccatgg accatgaaaa gatttatgag 30
<210> 14
<211> 30
<212> DNA
<213> Artificial sequence
<400> 14
attaggatcc tcatcgctca atagcttttc 30
Claims (9)
1. The ralstonia solanacearum effect protein RipXV is characterized in that the amino acid sequence of the ralstonia solanacearum effect protein RipXV is shown in SEQ ID No. 2.
2. Peanut ralstonia solanacearum effect protein geneRipXVCharacterized in thatRipXVA gene encoding the Ralstonia arachidicola effector protein RipXV of claim 1, whereinRipXVThe nucleotide sequence of the gene is shown in SEQ ID No. 1.
3. A gene comprising the ralstonia solanacearum effector protein of claim 2RipXVThe overexpression vector of (3).
4. A gene comprising the ralstonia solanacearum effector protein of claim 2RipXVThe knock-out vector of (1).
5. A transgenic plant comprising the ralstonia solanacearum effector protein gene of claim 2RipXVThe anaplerotic vector.
6. The protein interacting with the ralstonia solanacearum effector protein RipXV of claim 1, wherein the protein is NBS-LRR type disease-resistant protein AhRFL1, the nucleotide sequence of which is shown in SEQ ID No.3, and the protein sequence of which is shown in SEQ ID No. 4.
7. The use of the ralstonia solanacearum effector protein RipXV of claim 1 as an effector protein for eliciting a defense response, an allergic response in plants and/or for eliciting the expression of a disease resistance gene in plants.
8. The ralstonia solanacearum effector protein gene of claim 2RipXVThe application in culturing transgenic engineering bacteria with enhanced pathogenicity to flowers.
9. The use of claim 8, wherein the method for cultivating genetically engineered bacteria with enhanced pathogenicity to flowers is to use the genetically engineered bacteria in the original strainRipXVKnocking out genes, and screening to obtain transgenic engineering bacteria with enhanced pathogenicity to the peanut; the starting strain is peanut ralstonia solanacearum (A) (B)Ralstonia solanacearum)。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210674475.3A CN115109128A (en) | 2022-06-15 | 2022-06-15 | Peanut ralstonia solanacearum effect protein RipXV and coding gene and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210674475.3A CN115109128A (en) | 2022-06-15 | 2022-06-15 | Peanut ralstonia solanacearum effect protein RipXV and coding gene and application thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN115109128A true CN115109128A (en) | 2022-09-27 |
Family
ID=83328878
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210674475.3A Pending CN115109128A (en) | 2022-06-15 | 2022-06-15 | Peanut ralstonia solanacearum effect protein RipXV and coding gene and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115109128A (en) |
-
2022
- 2022-06-15 CN CN202210674475.3A patent/CN115109128A/en active Pending
Non-Patent Citations (3)
Title |
---|
A J BARRETT等: "Evolutionary lines of cysteine peptidases", 《BIOLOGICAL CHEMISTRY》, vol. 382, no. 5, pages 727 - 733 * |
GENBANK: "PREDICTED: Arachis hypogaea putative disease resistance protein At1g50180 (LOC112764213), transcript variant X4, mRNA", 《GENBANK》, pages 025809765 * |
GENBANK: "Ralstonia solanacearum strain HA4-1 plasmid HA4-1MP, complete sequence", 《GENBANK》, pages 022482 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105441460B (en) | A kind of Ming River lily WRKY transcription factor genes LrWRKY1 and application | |
CN110818782B (en) | Lilium regale WRKY transcription factor gene LrWRKY3 and application thereof | |
CN110317250B (en) | Application of MYB6 gene and encoding protein thereof in regulation and control of verticillium wilt resistance of plants | |
US11692200B2 (en) | Method for improving rice yield and/or rice blast resistance and protein used thereof | |
CN110317815B (en) | Gene for regulating and controlling adventitious root generation of populus euphratica, detection primer, expression vector and application | |
CN111574605B (en) | Application of rice gene OsLAT5 in regulation of absorption and accumulation of diquat | |
CN107267526B (en) | Radix Notoginseng myb transcription factor gene PnMYB2 and its application | |
CN113621625A (en) | Application of sesame SiERF103 gene in enhancing plant resistance | |
CN110818784B (en) | Application of rice gene OsATL15 in regulation of absorption and transportation of pesticides | |
CN110819634B (en) | Clone of lilium tenuifolium gene LpNAC6 and application thereof | |
CN114656530B (en) | Peanut bacterial wilt effector protein RipAU and application thereof in peanut bacterial wilt resistance | |
CN113881700B (en) | Application of arabidopsis AtSR33 gene in inhibiting turnip mosaic virus infection | |
CN111560055B (en) | Application of rice gene OsLAT3 in regulation of absorption and accumulation of diquat | |
CN115109128A (en) | Peanut ralstonia solanacearum effect protein RipXV and coding gene and application thereof | |
CN115724930A (en) | Tobacco NtMYB transcription factor and application thereof | |
CN111154770B (en) | Application of rice gene OsABCC2 in regulation of absorption and transportation of pesticides | |
KR20140043202A (en) | Drought stress resistant gene from potato and drought resistant transformant using the same | |
CN108017696B (en) | Chrysanthemum CmTFL1c gene and application thereof | |
KR101925468B1 (en) | Infectious clone of Papaya leaf curl virus and uses thereof | |
CN113789327B (en) | Dendrobium officinale constitutive strong promoter ProDoWOX1 and application thereof | |
CN113736798B (en) | Zinc-cadmium-resistant gene TmZRC1S from truffle and application thereof | |
CN116555286B (en) | Notoginseng rich proline protein gene PnPRPL1 and application thereof | |
CN116375838B (en) | Wheat translation initiation factor TaeIF4A and application thereof | |
CN114621962B (en) | Peanut AhBI-1 gene VIGS silencing system | |
CN113564182B (en) | Application of iris japonica SVP-like gene and method for obtaining iris japonica gene silencing or plant knockout |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |